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Abstract
Murine polyomavirus lytically infects mouse cells, transforms rat cells in culture, and
is highly oncogenic in rodents. We have used deep sequencing to follow
polyomavirus infection of mouse NIH3T6 cells at various times after infection and
analyzed both the viral and cellular transcriptomes. Alignment of sequencing reads to
the viral genome illustrated the transcriptional profile of the early-to-late switch with
both early-strand and late-strand RNAs being transcribed at all time points. A number
of novel insights into viral gene expression emerged from these studies, including the
demonstration of widespread RNA editing of viral transcripts at late times in
infection. By late times in infection, 359 host genes were seen to be upregulated and
857 were downregulated. Gene ontology analysis indicated transcripts involved in
translation, metabolism, RNA processing, DNA methylation, and protein turnover
were upregulated while transcripts involved in extracellular adhesion, cytoskeleton,
zinc finger binding, SH3 domain, and GTPase activation were downregulated. The
levels of a number of long noncoding RNAs were also altered. The long noncoding
RNA MALAT1, which is involved in splicing speckles and used as a marker in many
late-stage cancers, was noticeably downregulated, while several other abundant
noncoding RNAs were strongly upregulated. We discuss these results in light of what
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is currently known about the polyoma life cycle and its effects on host cell growth and
metabolism.
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I. INTRODUCTION

For over 60 years mouse polyomavirus has proven instrumental in the
understanding of both viruses from the Polyomaviridae family as well as the endogenous
host factors the virus utilizes to create the tumorigenic phenotype for which it is named.
Mouse polyomavirus is a small circular double-stranded DNA virus with a genome that is
only 5,327 base pairs. It consists of two divergent transcription units whose products are
alternatively spliced to produce mRNAs for the large, middle, and small tumor antigens
at early times and the VP1, VP2, and VP3 viral coat proteins at late times (Fig. 1). It is
through the interaction of the tumor antigens that the virus can alter host-signaling
pathways to drive the cell into S-phase to initiate the DNA replication the virus requires
in order to copy itself and undergo an early-late switch to begin producing viral coat
proteins. This thesis will focus on the biology of the mouse polyomavirus infection with
respect to both virus and host gene expression.

A. Mouse Polyomavirus Biology
1. Discovery
Mouse polyomavirus was discovered in 1953 when a cell free extract from mice
infected with a leukemia virus also caused the development of salivary gland tumors
when inoculated in newborn mice (Gross 1953). This tumor agent was cultured using
mouse embryo cells and was called “polyoma” for its ability to produce a variety of
tumors (Stewart 1958). The development of a polyoma plaque assay allowed for pure
strains of virus to be quantified by overlaying an infected monolayer of cells with an agar
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Figure 1. Map of transcription and splicing in the mouse polyomavirus.

Map of the circular doublestranded DNA genome of the mouse polyomavirus. Early
strand transcripts are shown in blue and the late strand transcripts are shown in red.
Alternative splicing of the early strand produces the Large, middle, and small t antigens
while the late strand splices into VP1, VP2, and VP3. Early and late transcripts are on
opposite strands flanking the noncoding control region, which contains the origin of
replication (marked as “ori”). Also shown are the polyadenylation sites which are
roughly opposite from the noncoding control region on the genome.
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nutrient mixture and counting the number of plaques that form when the cells lyse
(Winocour 1959). Media from polyoma cultures was shown to induce agglutination in
red blood cells allowing for the hemagglutination inhibition assay to be used to detect
antibodies against the virus (Eddy 1958) as well as measure the rate of adsorption
(Crawford 1962A). Antibodies from a variety of mouse colonies showed a positive
reaction for polyoma, indicating that the virus was already present in many mouse stocks
independent of strain (Rowe 1959). By culturing primary cells from the kidneys of
infected newborn mice, high titers of pure virus could be obtained (Winocour 1963). The
development of these techniques made it possible to study the virus in further detail.

2. Characterization
a. Transformation
Depending on the type of cells polyomavirus is cultured on, it either undergoes a
permissive “lytic” infection, where the cells produce large quantities of virus and are
lysed in the process, or a non-permissive “transforming” infection where the cells take on
the same tumor phenotype but do not produce virus. This transformation infection was
first observed when polyomavirus was cultured on hamster cells (Vogt 1960). Hamster
cells transformed by polyoma could be passaged and caused tumors when injected into
live animals but showed no evidence of virus production (Habel 1960, Vogt 1962).
Despite this lack of apparent virus production, antibodies to a tumor antigen of viral
origin could still be detected in the sera from animals injected with transformed virus-free
tumors when it was exposed to cell extracts from both mouse and hamster cells infected
with polyomavirus (Habel 1965). In addition, pulse labeled RNA from transformed cells
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showed hybridization to viral DNA (Benjamin 1966). Taken together, these experiments
suggested that viral gene products were still present in the transformed cells.
Experiments with polyoma and a similar primate virus SV40 showed transformed cells to
contain viral DNA integrated into the host genome (Sambrook 1968). Exposure of
polyoma to DNA damage via radiation before infection showed that the lytic infection of
mouse cells is roughly twice as sensitive to radiation compared to the transformation of
hamster cells, indicating roughly half of the viral genome is required for transformation
(Basilico 1965, Benjamin 1965, Laterjet 1967). Viral mutants were isolated that lost the
ability to grow in permissive mouse cell lines but could grow when cultured in mouse
cells that had already been transformed by a previous abortive polyoma infection
(Benjamin 1970). This indicated that the mutated viral gene products required for
transformation were provided by the genes integrated in the transformed cell line from
the previous infection, while the gene products necessary for a complete lytic infection
were still intact in the mutated virus. At this point transformation appeared to be
necessary but not sufficient for a complete lytic infection. We now know these mutants
were unable to express middle and small t antigens, which is why they could only infect
previously transformed cells. Since the mutants still expressed Large T, VP1, VP2, and
VP3, they could still replicate, undergo an early late switch, and complete a lytic
infection.

b. Structure
Electron microscopy of polyoma virus particles revealed two types of particles of
approximately 450 angstrom in diameter, full virus particles and empty capsids (Wildy
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1960). While both particles shared the same structure and ability to induce agglutination
in red blood cells, the two types of particles could be separated based on buoyant density
by centrifugation in rubidium chloride. Only the particles in the denser gradient were
able to infect cells, suggesting that the other gradient contained empty capsids (Crawford
1962B). The viral capsids were observed to be composed of 72 subunits or capsomeres
arranged in an icosohedral structure (Klug 1965, Finch 1974). When virus particles were
run on SDS-polyacrylamide gels, 7 distinct polypeptides could be identified, VP1, VP2,
VP3, and four mouse histone proteins H2a, H2b, H3, and H4 (Frearson 1972, Friedmann
1972, McMillen 1974, Roblin 1971, Seehafer 1974). VP1 is the largest and most
abundant capsid protein at ~48kDa, while VP2 and VP3 are 35 and 23 kDa respectively
(Hewick 1975). VP2 and 3 share polypeptide sequence with each other but not with VP1
(Friedmann 1976). This is because VP2 and VP3 are contained within the intron of VP1
(Kamen 1980).

c. Genome
Phenol extracted nucleic acid from polyoma infected mouse embryo cultures was
shown to lose its infectivity upon treatment with DNase but not RNase indicating a DNA
based genome (DiMayorca 1959). The polyoma virus genome showed a high resistance
to boiling and demonstrated spontaneous renaturation (Weil 1963A). When extracted
polyoma DNA was separated by velocity sedimentation, it produced components
consistent with both linear and circular genomes, both of which retained transforming
ability (Crawford 1964). Analytical ultracentrifugation of polyoma DNA showed three
types of sedimentation corresponding to super-coiled closed circlular double helices,
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genomes with a single stranded break, and double stranded linear molecules (Radloff
1967, Vinograd 1965, Vinograd 1968). These findings along with electron microscopy
demonstrated that the polyoma genome is circular and double-stranded (Weil 1963B).
When polyoma genomes were digested with the restriction enzyme Eco RI that only cuts
in one place on the genome and treated with the single stranded DNA binding protein 32
from bacteriophage T4, a single denaturation loop per molecule could be visualized by
electron microscopy at one of	
  three unique sites corresponding to A/T rich regions (Yaniv
1974). One of these sites would later be identified as part of the noncoding control
region. Electron microscopy of intact nucleoprotein complexes revealed chromatin like
structures with viral DNA bound to histones (Cremisi 1976). The first attempts to map
the polyoma genome used digestion by different combinations of restriction enzymes to
determine the order the fragments of viral DNA. This subsequently made it possible to
determine the relative location of restriction sites based on the order of the fragments
(Chen 1975). Restriction digestion of partially replicated intermediates (under 50%
replicated) allowed for the identification of the fragment containing the origin of
replication (Griffin 1974). Cleavage of partially replicated intermediates with the
restriction enzyme EcoRI made it possible to visualize the bidirectional replication of
polyoma using electron microscopy to determine the relative location of the origin
(Crawford 1973) and terminus (Crawford 1974) with respect to known restriction
digestion sites. Partial denaturation of polyoma fragments from different restriction
enzymes allowed for mapping of A/T rich regions using electron microscopy (Lescure
1975). Using a sequencing method (Maxam 1977) that involves chemically attacking
specific bases and running terminally radio-labeled DNA fragments on a polyacrylamide
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urea gel, the regions encompassing the origin and 5’ end of the early region (Friedman
1978), the early region (Friedman 1979, Soeda 1979), and the late region (Deininger
1979, Arrand 1980) were sequenced and found to have extensive homology with SV40.
The sequencing data and restriction maps were combined to make a complete map of the
polyoma virus genome (Deininger 1980, Soeda 1980).

d. Mutant analysis
Attempts to ascertain the functions of the different regions of the polyoma
genome were aided by the use of two major classes of polyoma mutants, temperaturesensitive and host range nontransforming mutants. Temperature-sensitive mutants
function like wild type at low temperatures (32°C) but lose transforming ability and viral
DNA synthesis at nonpermissive temperatures (39°C). Host range nontransforming
mutants are defective in their ability to transform wild type cells but function normally
when infecting cells that have already been transformed. Work with both kinds of
mutants has revealed a number of major insights into the function of the early and late
regions of the viral genome as well as the process of transformation by the early genes.

i. Temperature-sensitive mutants
In order to isolate temperature sensitive mutants of polyoma, large plaque strains
of polyoma were treated with nitric acid long enough to reduce viability of the virus to
between 1 in 10,000 to 1 in 100,000 surviving at 32°C. Of the surviving plaques 40 were
replated at both 32°C and 39°C and two temperature sensitive lines ts-a and ts-b showed
at least a 100 fold difference in plaque formation between 32°C and 39°C (Fried 1965).
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One of the temperature-sensitive mutants ts-a was found to induce host DNA replication
but failed to transform the host cell or synthesize viral DNA when cultured at
nonpermissive temperatures (Fried 1970).
When ts-a was shifted to a nonpermissive temperature after viral DNA production
initiated it was found that viral gene products were necessary for the initiation but not
completion of viral DNA synthesis (Francke 1973). Assessment of six different
temperature sensitive mutants that were isolated using similar methods showed three
kinds of mutations. At nonpermissive temperatures class I mutants failed at making
infectious viral particles, class II mutants were unable to transform cells or synthesize
viral DNA, and class III mutants could transform cells but could not synthesize viral
DNA. Mutants unable to synthesize viral DNA were called “early” and mutants that
make viral DNA but fail to produce virus particles were called “late” (Eckhart 1969).
Both “early” and “late” mutants were able to induce cellular DNA synthesis (Eckhart
1971A). Experiments to determine the cause of the inhibition of cellular transformation
and viral DNA synthesis found that at nonpermissive temperatures, “early” mutants were
defective in T antigen expression but “late” mutants were not. In addition, treatment of
infected cells with DNA replication inhibitors did not affect T antigen expression in
either wild type or mutants at permissive temperatures (Oxman 1972). Late mutants such
as ts-59 were shown to express altered versions of all three viral coat proteins at
nonpermissive temperatures that failed to form stable virus particles but could be
complemented by the functioning coat proteins from early mutants such as ts-a (Gibson
1977). Cells infected with temperature-sensitive mutants defective in their ability to
transform cells at nonpermissive temperatures did not revert to an untransformed
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phenotype when switched to a nonpermissive temperature (Dimayorca 1969). This
indicated that the disrupted viral genes are necessary for the initiation, but not
maintenance, of the transformed phenotype.
Another temperature sensitive mutant, ts-3, was used to show that certain
hallmarks of a transformed phenotype could be rendered temperature dependent. At
nonpermissive temperatures, cells infected with ts-3 did not demonstrate a loss of
topoinhibition, the halting of DNA replication when cells become too dense (Dulbecco
1970). In addition, ts-3 renders the reduction in extracellular proteins that normally
occurs during transformation, temperature dependent (Eckhart 1971B). The ts-3 mutant
was also shown to have different sensitivities in different host cell types, failed to
complement with other mutants, and decreased temperature sensitivity when fresh
medium and serum was added at a nonpermissive temperature (Eckhart 1974). When
RNA from cells infected with ts-3 was annealed to radiolabeled viral early DNA, it failed
to accumulate at nonpermissive temperatures indicating the temperature sensitivity
affected early transcription (Cogen 1977). These observations were likely the result of
the temperature sensitivity affecting the ability of the ts-3 virus to uncoat and release viral
DNA at non permissive temperatures. This explains the lack of transcription as well as
the lack of transformation hallmarks.
Taken together these experiments with temperature sensitive mutants demonstrate
the primary functions of viral genes are to transform host cells, initiate viral DNA
replication, and produce viral coat proteins.
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ii. Host range nontransforming mutants
Early investigation into polyoma gene function required a way to culture mutant
virus in order to observe loss of function. Unfortunately, most viral mutants could not be
cultured directly since so much of the viral genome is critical for the viral life cycle. One
strategy to overcome the problem was the use of temperature sensitive mutants. Another
approach was to use what are called host range nontransforming mutants or “hr-t
mutants”. Hr-t mutants are unable to grow in normal mouse cells but they can grow in
mouse cells that have been previously transformed. When infected with polyoma, mouse
3T3 cells can undergo both lytic infection and abortive transformation in which some of
the cells do not produce virus particles but instead integrate viral genes in the host
genome (Sambrook 1968). Transformed 3T3 cells that do not produce virus particles can
be cultured and used as hosts for virus mutants defective in their ability to transform
cells.
In order to isolate transformed virus-free cells, mouse 3T3 cells were infected
with polyoma virus and plated in soft agar suspension to select for transformed cells.
Antiviral serum and receptor destroying enzyme was added to prevent reinfection of the
transformed virus-free cells. This resulted in 9 clones that could be recultured in antiviral
conditions. Of these only one clone, 3T3 Py3, was able to be both infected and
maintained indefinitely. Polyoma virus was mutagenized with either nitrosoguanidine
(NG) or hydroxylamine (HA) and cultured on both 3T3 and 3T3Py3 cells. Out of the 900
NG and 360 HA plaques tested only 3 NG (NG-18, NG -23, NG-59) and 1 HA (HA-33)
isolates showed strong plaque formation on 3T3 Py3 with no plaque formation on 3T3
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(Benjamin 1970). These mutants were called host range nontransforming mutants
because of their altered host range caused by an inability to transform cells.
Host range nontransforming mutants have proven invaluable for discovering viral
gene functions as well as corroborating with temperature-sensitive mutant experiments.
The hr-t mutants, like the temperature sensitive mutant ts-3, have also shown an inability
to demonstrate reduced extracellular protein expression normally associated with
transformation despite successfully entering the host cell and expressing viral genes
(Benjamin and Burger 1970). An interesting observation from experiments with the hr-t
mutant NG-18 was its ability to grow in a variety of mouse cell types including cells
transformed by murine leukemia virus as well as cells in a less differentiated state such as
mouse embryonic fibroblasts. This meant that host cells did not need an integrated
polyoma gene or even all of the traits associated with a transformed phenotype to be able
to support hr-t growth. The transformed cells that were not good hosts for hr-t mutants
included cells transformed by SV40 or spontaneously through mutation (Goldman 1975).
Because of hr-t mutants’ inability to transform cells, they also could not transform rat or
hamster fibroblasts (Siegler 1975). These observations are consistent with the current
understanding that the middle and small t antigens were inactived in hr-t mutants (Hattori
1979). Middle and small t antigens are responsible for the transformed phenotype and
are necessary for the expression of the host factors required for viral DNA synthesis.
Both embryonic fibroblasts and cells transformed by mouse leukemia virus would likely
have had such factors expressed at a sufficient level to compensate for loss of middle and
small t. Interestingly, despite being unable to transform host cells, hr-t mutants were still
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able to express Large T antigen and synthesize viral DNA in nonpermissive 3T3 cells
(Staneloni 1977).
At the time it was not understood how mutated viral genes prevented
transformation or where in the viral genome they were located. Using a technique that
replaces regions of hr-t virus with wild type sequence via restriction digestion, the
disrupted region of hr-t mutant NG-18 was rescued when replaced with wildtype
sequence near the promoter of the transcript expressed at early times. This same
approach also revealed the general locations of other temperature sensitive mutants such
as ts25D (a type of ts-a mutant), ts-3, and ts-1260 as mapping to the distal early region,
proximal late region, and distal late regions respectively (Feunteun 1976). It would later
be understood that the proximal early region mutated in hr-t mutants like NG-18 affected
the splicing of middle and small t but not Large T antigens (Hattori 1979).
Another process affected by hr-t mutation is the status of the viral chromatin.
Previous observations of wild type polyoma have shown that viral chromosomes are
highly acetylated on histones H3 and H4 (Frearson 1972, Schaffhausen 1976). This
acetylation was not observed in hr-t mutants indicating the necessity of host
transformation for viral chromosome packaging (Schaffhausen 1976). Results from these
experiments have been replicated in a number of other hr-t mutants leading to a model of
hr-t genes inducing host permissivity factors required for transformation, virus growth,
and acetylation of host histones incorporated into viral chromosomes. It was later
determined that small t antigen specifically is responsible for the hyperacetylation of viral
chromatin in a manner dependent on its association with protein phosphatase 2A (Dahl
2007).
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While the mechanism of culturing hr-t mutants and temperature sensitive mutants
is different, both kinds of mutants have the ability to complement each other when
infecting the same cell. Studies of both hr-t and ts-a mutants showed complementation
for transformation and growth at high ts-a to hr-t ratios. Complementation between both
types of mutants is reciprocal in both untransformed mouse 3T3, hamster BHK, and rat
Y1 cells and at nonpermissive temperatures (Eckhart 1977). Unlike hr-t mutants, ts-a
mutants were unable to grow in cells transformed by murine leukemia virus. These
experiments indicated that the mutants were defective in different viral early gene
functions, suggesting multiple functions for viral early genes (Fluck 1977). Both wild
type and temperature sensitive mutants at nonpermissive temperatures were shown to
induce DNA replication in the host cell for multiple rounds while hr-t mutants only
induced a single round (Schlegel 1978). Comparisons between polyoma and SV40
versions of temperature sensitive and hr-t deletion mutants showed that the temperature
sensitive mutants lose the ability to maintain transformation but not the ability to initiate
it while polyoma hr-t and SV40 hr-t deletion (dl) mutants are largely unable to initiate
transformation (Fluck 1979). Sequence analysis of the hr-t region of a variety of hr-t
mutants revealed the C terminal region of smaller early gene products, but not the large T
antigen, were not expressed (Hattori 1979). Both kinds of mutants can now be
understood with regards to the viral genes being disrupted. Loss of Large T antigen
precludes viral DNA synthesis but not cellular transformation. Loss of middle and small
t antigens precludes cellular transformation. Loss of viral coat proteins either precludes
completion of a lytic infection, or in the case of ts-3, results in a loss of the ability of
virus particles to properly uncoat and transcribe viral DNA.
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e. Transcription
Study of the transcription of polyoma RNA at different stages of viral infection
was made difficult by the variability in the onset of virus induced DNA synthesis at the
individual cell level. For this reason the DNA replication inhibitor 5-fluorodeoxyuridine
(FdU) was used to synchronize polyoma-infected cells. This allowed detection of
polyoma RNA via hybridization to viral DNA of both low abundance “early” RNA and
extremely high abundance “late” RNA expressed before and after DNA replication
respectively (Hudson 1970). In the presence of DNA replication inhibitor FdU,
transcription of early RNA was followed by the expression of tumor antigen leading to
the cell expressing mitogenic factors and increasing the expression of ribosomal RNA
(Salomon 1977). This was consistent with a role of early gene products in driving DNA
replication.
Analysis of cytoplasmic polyoma RNA from late times in infection resolved 3
species of RNA, two of which hybridized to the late region and one that covered most of
the early region (Kamen 1976, Turler 1976). In vitro translation of the cytoplasmic long
and short late region RNAs revealed they code for the capsid proteins VP2 and VP1
respectively (Smith 1976, Kamen 1978). At early times in infection both nuclear and
cytoplasmic RNA was shown to be complementary to 40% of the early strand of the viral
genome with a small amount complementary to the late strand in the nucleus (Acheson
and Mieville 1978). At late times nuclear RNA was shown to be complementary to all of
the late strand and 60% of the early strand while cytoplasmic RNA was only
complementary to 45% of the early strand and 55% of the late strand. Taken together
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this indicated that the smaller cytoplasmic gene products were likely derivatives of the
larger nuclear RNAs (Beard 1976). This is remarkable because it was a good example of
alternative splicing before splicing had been elucidated. The small size of the viral
genome coupled with the difference in the percentage of the viral genome hybridized to
nuclear and cytoplasmic RNA, indicated that some process was changing the length of
cytoplasmic RNA.
Experiments looking at the viral transcripts produced at late times by
electrophoresis and sucrose gradient centrifugation revealed surprisingly large RNA
multiple times longer than the polyoma genome that are processed into smaller species
(Acheson 1971). Radiolabeled RNA from late times in infection was found to be highly
resistant to RNase treatment due to self-annealing. This indicated symmetrical
transcription of both strands was occurring across the whole genome at late times (Aloni
1973). Isolation of polyoma RNA from late times in infection using oligo(dT) cellulose
chromatography showed approximately 15% of giant transcripts were polyadenylated.
When treated with the DNA replication inhibitor FdU, late polyoma transcripts no longer
exceeded the length of the polyoma genome indicating a dependence of giant transcript
production on DNA replication (Rosenthal 1976). The presence of giant nuclear viral
late transcripts with inefficient polyadenylation at late times of infection was confirmed
using Southern mini-blot hybridization (Birg 1977) and in vitro transcription (Condit
1977). The polyadenylation of giant transcripts was found to be consistently on the 3’
end of the late region indicating that it was not terminating at various locations (Lev
1979). Electron microscopy of giant RNAs hybridized to restriction-digested polyoma
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DNA containing 91% of the genome showed that the giant transcripts were contiguous
tandem repeats of the whole genome and not the result of splicing (Acheson 1978).
Analysis of the 5’ ends of late polyoma mRNAs via Ribonuclease T1
fingerprinting revealed a variable number of copies of a “late leader sequence” resulting
from splicing out whole genome sized introns from the giant transcripts (Legon 1979B,
Treisman 1981A). The observed difference in the rate of RNA export from the nucleus
to the cytoplasm between RNA at early times and RNA at late times is consistent with
giant late RNA precursors undergoing more processing. At early times radiolabeled
uridine was seen in the cytoplasmic fractions <6 minutes after it was seen in nuclear
fractions, while at late times the difference was between 12 to 20 minutes (Acheson
1981). This makes sense if there are longer RNAs to process at late times than at early.
The tandem repeats of late leader sequences were visualized by electron microscopy of
the loops cause by hybridizing late mRNA to genomic sequence (Zuckermann 1980).
Complete digestion of viral mRNA with RNase T1, T2, and A, followed by 2D
electrophoresis revealed a variety of 5’ cap structures (Flavell 1979). When the cap
structures were removed and the 5’ ends of late mRNAs were sequenced, they were
found to have variable sequences upstream of the late leader (Flavell 1980, Cowie 1981).
The location of the 5’ cap with respect to the viral sequence was found to be dependent
on the ratio of available nucleotides when transcribed in vitro indicating variability in
transcription start sites (Cowie 1982). Comparison between early and late transcription
in vitro in HeLa whole cell extracts showed early transcripts to be consistently expressed
but late transcripts showed lower expression than in vivo and the variability in late 5’
capping was not observed. Late transcription was also affected by the concentration of
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template in vitro (Jat 1982A). Mapping of the 5’ ends of early strand mRNAs via
hybridization to a HinfI restriction fragment spanning the noncoding control region
followed by S1 nuclease digestion of unhybridized strands and electrophoresis showed
the majority of early mRNAs are principally capped between nucleotides 147 and 152
with minor species found to be capped in the early coding region. At late times species
were found to have 5’ capping occurring further upstream before the origin of replication
consistent with either a shift in transcription start sites or contamination from giant
transcripts (Kamen 1982)(Fig. 2).
Hybridization of the three cytoplasmic late mRNAs to the viral genome protected
sequences from digestion by S1 nuclease. This allowed for the precise splice sites of
VP1, VP2, and VP3 to be determined by comparing hybridization with a variety of
restriction fragments to the known sequence of the late region (Kamen 1980).

f. Noncoding control region
The area of the polyoma genome containing the origin of replication, enhancers,
the early and late promoters, and large T antigen binding sites is called the noncoding
control region (Fig. 3). Much of what is understood about this region has come from
deletion experiments to determine which areas affect transcription efficiency or DNA
replication. Comparisons between the sequence of wild type polyoma and mutants
capable of replicating in embryonic carcinoma cells also revealed key regulatory
sequences.
The origin of replication consists of an A-T tract followed by a GC rich inverted
repeat that is necessary for DNA replication. GC to AT base substitutions in the GC rich
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Figure 2. Shift in the transcription start site of the early strand late in infection.

The noncoding control region is shown in black for both early and late times in infection.
Early strand transcripts are shown in blue, late are shown in red. The early strand
transcribes from the TATA box to the right of the origin at early times. The late strand
transcribes from the enhancer A region . At late times the early strand transcription shifts
back towards the enhancer A region.
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Figure 3. Enhancers and host transcripton factor binding sites in the polyoma
noncoding control region

The 4 enhancers of the polyoma noncoding control region A-D are shown on the late side
of the origin. The major host transcription factors that bind to the enhancers are also
shown. The origin, Large T binding sites, and early and late transcription start sites are
shown with the A enhancer also functioning as a late transcription initiation site.

(This image was modified from Martelli J Virol 1996)

21	
  

	
  

22	
  

	
  
region were found to disrupt DNA replication when they were closer to the center of the
inverted repeat (Triezenberg 1984). The introduction of deletion mutations in the
noncoding control region between the origin and the late coding sequence demonstrated
the existence of an enhancer element required for efficient expression of early transcripts
(Tyndall 1981). When the polyoma transcriptional enhancer was inserted into a plasmid
containing the rabbit hemoglobin beta-1 gene, it strongly enhanced expression of rabbit
transcripts over a distance of 1400 bases (de Villiers 1981). Using the same beta-globin
plasmid based approach, enhancers from polyoma and SV40 were both tested in mouse
and primate cells and demonstrated a cell type preference (de Villiers 1982).
The transcriptional enhancer region was also found to be necessary for DNA
replication. Deletion mutants were not only shown to have a strong negative effect on
DNA replication from loss of the A-T tract but also when a section containing the
transcriptional enhancer starting 60 bases into the late region and stopping in the middle
of the late coding region was removed. The inability of wild-type virus to rescue these
mutants demonstrated that the missing sequences function in cis (Luthman 1982).
Plasmids containing a 251 base segment of the polyoma non-coding control region were
expressed in MOP cells that express polyoma large T antigen to make them permissive
for polyoma DNA replication. Mutation analysis revealed three regions necessary for
polyoma replication, the core consisting of an A/T tract followed by a GC rich
palindromic sequence, a sequence upstream of the core in the enhancer region called B
that has no apparent features, and a sequence further toward the late region called A that
can substitute for B’s role in DNA replication (Muller 1983). When the polyoma
enhancer region was removed the virus lost the ability to replicate. Addition of an SV40
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or immunoglobulin enhancer both restored DNA replication in cis and altered cell type
specificity (de Villiers 1984). Further analysis of the enhancer region found redundant
enhancer elements also required for DNA replication. When the region was deleted and
copies of a 26 base element were introduced only two copies were required to restore
DNA replication ability irrespective of orientation. Two additional enhancer domains, C
and D were also identified (Veldman 1985).
Embryonal carcinoma (EC) cells were used to study regulation of transcription
and DNA replication in viral genes because wild-type virus was shown to grow poorly in
this cell type but could be compared to mutant virus that can express early and late genes
in EC cells. EC cells express lower levels of the c-Fos/c-Jun and ets family of
transcription factors required for viral transcription. The duplications in the recognition
sites for these proteins on the viral genome allowed the mutants to compensate for low
expression levels (Nothias 1993). These mutants were first isolated from virus that grew
on EC cells differentiated into fibroblasts and were selected based on their ability to grow
in undifferentiated EC cells. The mutants showed the same functionality and host range
as the wild type and differed only in a 10-50 bp duplication of sequence on the late side
of the origin in the noncoding control region (Katinka 1980, Katinka 1981, Vasseur 1980,
Dandolo 1983). Comparison between the DNase I hypersensitive regions of wild type
and EC mutant noncoding control regions showed the same DNAse I profile of two
hypersensitive regions on the late side of the origin despite different sequence, due to a
GC rich palindrome common to both wild type and mutant that provides protection
between the two regions (Herbomel 1981). Each of the hypersensitive regions was found
adjacent to an enhancer element in both wild-type and mutant virus (Herbomel 1984).
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When wild-type and mutant virus were both grown in embryonic carcinoma cells, the
mutants failed to rescue wild-type DNA replication (as indicated by differing restriction
fragment size length) suggesting the differing sequence in the noncoding control region
of the mutants was acting in cis (Fujimura 1982).
The polyoma A and B enhancers were found to function as binding sites for host
factors. When the B enhancer from polyoma was incubated with proteins from the nuclei
of 3T6 cells, at least two factors called polyoma enhancer B binding proteins 1 and 2
(PEB1 and PEB2) were found to cause band shifting and protect a GC rich palindromic
region homologous to immunoglobulin and SV40 enhancers from Dnase I digestion
(Piette 1985). Similar attempts to reveal the factors binding to the A enhancer found two
proteins called polyoma enhancer A binding protein 1 and 2 (PEA1 and PEA2). PEA1
was also found to bind to SV40 and c-fos enhancers suggesting it is the same protein as
the human activator protein 1 (AP-1) (Piette 1987). A third type of protein was found to
bind to polyoma enhancer A called PEA3 that cooperates with PEA1 in response to
upstream oncogene expression but unlike PEA1 is not dependent on c-fos (Martin 1988,
Wasylyk 1989). PEA3 was found to be the same as the transcription factors produced by
the ets-1 and ets-2 proto-oncogenes (Wasylyk 1990). Interestingly, in addition to
functioning as an enhancer for early transcription and DNA replication, the PEA1 and
PEA3 binding sites also facilitate the initiation of late transcription in lieu of a TATA
binding by the TFIID complex (Yoo 1991). Another protein, called Enhancer Factor 1A
(EF-1A), previously shown to bind to the E1A enhancer region in adenovirus, was
identified through enhancer fragment competition to bind to 1 site in the A enhancer
domain and 2 sites in the B enhancer domain. This interaction was shown to be sufficient
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to stimulate some replication of polyoma in vivo (Bolwig 1991). The D enhancer domain
was shown to bind to a common host transcription factor NF-D, which is a member of the
NF-1 family (Caruso 1990). This factor was later shown to be the same as YY1, which
can positively activate transcription of the late promoter (Martelli 1996). Interestingly,
YY1 also directly binds to the late protein VP1, suggesting a possible role for VP1 in
recruiting transcription factors in the upregulation of the late promoter (Palkova 2000).
The proteins PEA2, PEA3, and NF-D have different effects on the early and late
promoters under nonreplicating conditions. All three factors activate early promoter
transcription in a combinatorial manner while PEA2 and 3 repress late promoter
transcription in a manner dependent on direct interaction between the two proteins
(Shivakumar 1998).
The activity of enhancer binding proteins PEA1 and PEA3 with respect to viral
transcription and replication has also been shown to be significantly influenced by middle
and small t antigens. The host range nontransforming mutants (hr-t) of polyoma fail to
express middle and small t antigens but compensate for the lack of downstream effects of
these proteins with a duplication of the A enhancer to rescue some DNA replication
ability. When hr-t mutants were treated with the phorbol ester 12-Otetradecanoylphorbol-13-acetate (TPA) to stimulate the pathways leading to an increase
in the expression of PEA1 and PEA3, more of the DNA replication defect was rescued.
When middle and small t were expressed in the presence of hr-t mutants with and without
the duplication of the A enhancer the differences in DNA replication between them were
abolished and replication efficiency was restored (Chen 1995). In addition to being
necessary for viral DNA replication, middle and small t antigens are also necessary for
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increasing late transcription at late times. When untreated hr-t mutants were compared
with wild type virus treated with DNA replication inhibitor cytosine β-Arabinofuranoside
(AraC) after entering the late phase, the wild type still showed higher levels of late
transcription even with fewer genomes indicating that the reduction in late transcripts is
not an indirect result of fewer templates from inefficient replication but from a direct
reduction in late transcription (Chen 2001). The major pathways activated by middle T
(Shc, PI3K, and PLCγ), along with small t antigen each additively contribute to the
upregulation of PEA1 and PEA3 resulting in an increase in both viral DNA replication as
well as late transcription (Chen 2006).
On the early side, the deletion of bases 200-400 base pairs before the 5’ cap sites
resulted in a loss of transforming ability but still produced RNA in vitro. The TATA box,
the 5’ cap site, and 90-100 bases of nonspecific spacer sequence are required for efficient
in vitro transcription of the early region to occur (Jat 1982B). Deletion mutations on the
early side from bases 20 to 86 abolished DNA replication in COP5 cells that express
large T antigen with smaller deletions resulting in proportionally decreased DNA
synthesis (Katinka 1983).
These experiments allowed for a mapping of the major functional sequences in
the noncoding control region. The origin of replication, the early Large T antigen
binding sites, the TATA box on the early side but not the late, and the enhancers of
transcription and replication make up the majority of the sequence. Understanding of the
factors that bind to the noncoding control region is important for both identifying causes
of host cell specificity as well as demonstrating downstream effects of early proteins such
as Large middle and small t antigens and the transcription factors they activate.
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g. Tumor antigens
The early gene products of polyoma virus are the large, middle, and small tumor
antigens that are necessary for transformation and DNA replication. Initial attempts to
identify the tumor antigens by in vitro translation produced three proteins of ~90kDa,
60kDa, and 22kDa (Fig. 4). Unspliced early viral cRNA was unable to translate into
Large or middle T but could translate into small t, indicating the presence of an intron.
The sequences downstream of the splice site were found to be on different reading frames
for each T antigen (Hunter 1978). Upstream of the splice site all of the tumor antigens
were found to share a common N terminal sequence (Hutchinson 1978, Smart 1978)
containing a highly conserved J domain that binds to the 70kDa family of host heat shock
proteins (Cheetham 1992, Kelley 1994). Large, Middle, and small T antigens were
expressed individually in Py-SV40 recombinants and shown by immunofluorescence to
localize to the nucleus, cell membrane, and both nucleus and cytoplasm respectively (Zhu
1984).
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Figure 4. Functional regions of polyoma tumor antigen proteins

All three of the tumor antigens share a J domain in their common N terminal regions but
differ in their C terminal regions by each splicing to a different reading frame. Large T
antigen has a nuclear localization signal and pRb-binding site in the region that is spliced
out of middle and small t. Middle T has a hydrophobic region near the C terminus for
cell membrane localization and a binding site for PP2A at the N terminus that it shares
with small t. Middle T has unique binding sites for pp60c-src and can bind Shc, PI3K,
and PLC-gamma1 when tyrosines 250, 315, and 322 are phosphorylated respectively.
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i. Large T antigen
When the polyoma Large T antigen was expressed alone in fibroblasts from
mouse and rat embryos, the cells demonstrated an “immortalized” phenotype in which
they would grow indefinitely in lower serum concentrations but maintained an
untransformed appearance. This immortalization also occurred when only 40% of the
Large T antigen from the N terminal region was expressed indicating this region
contained the necessary domain (Asselin 1985, Holman 1994, Rassoulzadegan 1983).
This process was found to be dependent on interaction between Large T antigen and
retinoblasoma family of tumor suppressor proteins. When the region of Large T
necessary for binding to retinoblastoma proteins was mutated, a loss of immortalization
of rat embryo fibroblasts was observed (Larose 1991). Viral genomes mutated to
preclude binding of Large T to retinoblastoma proteins while expressing wild type middle
and small t antigens still retained the ability to produce a transformed phenotype and
tumors (Freund 1992). In vitro coimmunoprecipitation showed polyoma Large T antigen
forms a complex with both human and mouse retinoblastoma tumor suppressor proteins
pRB and p107 (Dyson 1990, Pilon 1996). The pRB binding domain of Large T fused
with GST was immobilized on glutathione-sepharose beads and shown to bind to in vitro
translated C terminal domains of pRB and p107, as well as an additional p130
retinoblastoma protein (Desjardins 1997).
The downstream effects resulting from the interaction between Large T antigen
and pRb were found in some cases to be dependent on the conserved DnaJ domain
common to the N terminal regions of all T antigens in addition to the pRb binding region.
The DnaJ domain binds to DnaK proteins such as host heat shock chaperone Hsc70 and
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stimulates ATP hydrolysis (Cheetham 1992). When Large T antigen was mutated in its
pRb binding region or its DnaJ domain, the two mutants were unable to complement each
other for downstream effects related to E2F promoter activation, suggesting a role for
direct Hsc70 binding to facilitate Large T interactions with pRb (Sheng 1997). Despite
this, Large T mutated in J domain binding to Hsc70 still demonstrated the ability to
induce apoptosis in differentiating myoblasts, activate the cyclin A promoter, and alter
phosphorylation of pRb and p130 (Sheng 2000).
Unlike SV40 Large T antigen, which was found to bind to the p53 tumor
suppressor protein (Lane 1979, Linzer 1979), polyoma Large T antigen does not bind
directly (Wang 1989). Expression of polyoma Large T antigen in mouse embryo
fibroblasts with a temperature sensitive p53 produced the same loss of downstream
effects of p53 (such as expression of p21 and hypophosphorylation of Retinoblastoma
proteins) as nonpermissive temperatures. This loss of downstream effects was not
observed when Large T mutated in its ability to bind retinoblastoma was expressed,
indicating a dependence on the binding of Large T to pRb to overcome the effects of p53
and prevent apoptosis or inhibition of DNA replication (Doherty 1997). In essence, the
expression of functional Large T antigen in these cells had the same effect on
downstream targets of p53 as temperature sensitive p53 at nonpermissive temperatures.
Immunopurified Large T antigen was found to bind to three regions of the viral
genome between the origin of replication and the early coding sequence. Each of the
binding regions contain repeats of the sequence G(A/G)GGC (Cowie 1984, Dilworth
1984). Large T mutants unable to bind to the polyoma genome still retained the ability to
immortalize rat embryo fibroblasts (Cowie 1986). Like SV40 Large T, polyoma Large T
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was also found to function as a helicase to unwind double stranded DNA. Unlike SV40
Large T, polyoma Large T is able to unwind DNA of sequence unrelated to the polyoma
origin of replication in vitro if the ratio of Large T to DNA is 100:1 (Wang 1991). The C
terminal region of Large T antigen consisting of residues 264-785 was found to be
sufficient for DNA replication but required complementation with the N terminal region
to immortalize cells and replicate under low serum conditions (Gjorup 1994).
Using coimmunoprecipitation and GST pulldown, polyoma Large T antigen was
found to bind to a subspecies of p300 with histone acetyltransferase activity (Nemethova
1999), which along with CBP is known to regulate genes that respond to cyclic AMP
(Arany 1994, Arany 1995, Eckner 1994, Lundblad 1995). This association was found
through a region of Large T with a high level of homology to SV40 Large T and
Adenovirus E1A proteins previously shown to bind to p300/CBP (Arany 1995, Eckner
1996). Polyoma Large T was also found to bind to CBP at the N terminal Domain (1771) and one of the middle domains (1069-1892) and p300 at the N terminal (1-596) and
C terminal (1572-2370) domains in a manner independent of p53, NFkB, or ability to
bind to pRb (Cho 2001). This demonstrates an additional way Large T can stimulate cell
cycle progression besides binding directly to retinoblastoma proteins.
Polyoma mutants able to grow in cancer cells but not in normal cells expressed
Large T with a C terminal region deficient in binding to the DNA replication inhibitor
p150Sal2 (Li 2001). p150Sal2 is a tumor suppressor gene that binds to the promoters of the
p53-regulated, p21 and BAX tumor suppressor genes and stimulates their expression
independently of p53 to inhibit DNA replication and cell division (Li 2004). The gene
products of the SALL2 gene including p150Sal2 are involved in driving serum-starved
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cells into a quiescent state (Liu 2007). This suggests the binding of Large T antigen to
p150Sal2 in addition to binding pRb is related to the ability of Large T to drive replication
even in low serum conditions.
These interactions demonstrate a variety of roles for Large T antigen in the viral
lifecycle of interacting with both the viral genome and cellular factors involved in cell
cycle progression. Large T can immortalize cells and inhibit downstream effects of p53
by binding to the retinoblasoma family of proteins, prevent serum starved quiescence,
and bind to the viral genome to function as a helicase in viral DNA replication.

ii. Middle T antigen
The polyoma middle T antigen is the primary driver of the transformed phenotype
in host cells (Ito 1980). When virus expressing only functional middle T was expressed
in rat cells, a transformed phenotype was still observed, indicating that middle T is
necessary and sufficient for cellular transformation (Treisman 1981B). Middle T
contains a hydrophobic C terminus that anchors it to the cell membrane (Ito 1977, Ito
1979, Silver 1978). When middle T was truncated at the C terminus and expressed with
wild-type Large and small t antigens, it no longer localized to the cell membrane and the
transformed phenotype was no longer observed (Carmichael 1982). Middle T is
associated with the cell membrane on the inner side and does not possess ATP-binding
activity (Schaffhausen 1982).
Immunoprecipitates of polyoma T antigens demonstrated the ability to
phosphorylate middle T on tyrosine residues (Eckhart 1979). Through a series of
deletion mutations, middle T was found to be phosphorylated on a tyrosine at residue 315
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(Schaffhausen 1981). This activity was the result of an association between middle T and
the cellular kinase pp60c-src (Courtneidge 1983, Bolen 1984, Balmer-Hofer 1985), pp62cyes

(Kornbluth 1987), or pp59c-fyn (Horak 1989). When the tyrosine at residue 315 was

mutated to phenylalanine to preclude phosphorylation, middle T showed a dramatic
reduction in ability to induce a transformed phenotype (Carmichael 1984). The extent of
transformation of rat F-111 cells by inducibly expressed middle T was found to correlate
more with the level of phosphorylated middle T rather than the total amount of middle T
expressed (Raptis 1985). Analysis of middle T peptides digested with trypsin and
phosphorylated in vitro with radiolabeled phosphates revealed a second major
phosphorylation site at tyrosine 250 (Hunter 1984). Antisera against the region of middle
T containing tyrosine 315 still showed phosphorylation at tyrosine 250, while antisera
against middle T in general showed additional phosphorylation at tyrosine 322 in vitro
(Harvey 1984). Unlike phosphorylation of 315, phosphorylation of tyrosine 322 was
found to be dispensable for transformation (Magnusson 1981, Schaffhausen 1985).
Immunoprecipitates made with antisera to Middle T antigen not defective in
transformation were shown to have a phosphatidylinositol kinase activity in vitro and in
vivo, while middle T mutants defective in transformation did not (Whitman 1985, Kaplan
1986). This demonstrated a dependence of middle T transformation on
phosphatidylinositol metabolism. When 3T3 cells were either treated with platelet
derived growth factor (PDGF) or transformed with polyoma middle T, to stimulate the
phosphorylation of proteins on tyrosine, anti-phosphotyrosine immunoprecipitates
included an 81-85 kDa phosphoprotein that coincided with high phosphatidylinositol
kinase activity (Kaplan 1987). The protein was found to complex with middle T and
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pp60c-src (Courtneidge 1987) in a manner dependent on the phosphorylation of tyrosine
315 on middle T (Talmage 1989). This protein was called phosphatidylinositol-3-kinase
(PI3K) for its ability to phosphorylate phosphatidylinositol at the D-3 position (Whitman
1988). Polyoma transformed 3T3 cells show PI3K activity in the form of elevated
phosphatidylinositol-3-phosphate, phosphatidylinositol-3,4-bisphosphate, and
phosphatidylinositol trisphosphate that is not observed in uninfected cells (Serunian
1990).
In addition to the 85 kDa PI3K protein associated with middle T, a 61-63 kDa and
a 36-37 kDa protein were found in complex with polyoma middle T, polyoma small t, or
SV40 small t antigens (Pallas 1988). These proteins were identified as the A (regulatory)
and C (catalytic) subunits of the serine and threonine Protein Phosphatase 2A (PP2A)
respectively (Pallas 1990, Walter 1990). PP2A associates with both middle and small T
antigens through their common N terminal regions, upstream of the splice site, that
mimic the cellular B subunit. Biochemical analysis revealed that the association of
middle T with PP2A is necessary for binding of pp60c-src and related proteins (Campbell
1995). Inhibition of the phosphatase activity of PP2A with okadaic acid reduced PP2A
association with middle T as well as the amount of pp60c-src bound to middle T (Glover
1999). Interestingly, mutations causing inactivation of the catalytic activity of the C
subunit of PP2A precluded interaction with the cellular regulatory B subunit but did not
preclude association with middle T or recruitment of pp60c-src (Ogris 1999). This
suggested that the reduction in association of PP2A with middle T in the presence of
okadaic acid was not purely the result of a loss of catalytic activity.
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The Src homology 2 containing protein (Shc) was found through
immunoprecipitation experiments to bind to middle T antigen in a manner dependent on
phosphorylation of middle T at Tyrosine 250 at the NPTY motif. This association results
in the phosphorylation of Shc by pp60c-src, leading to the binding of Shc by Grb2,
mimicking the signaling cascade of a tyrosine kinase associated growth factor receptor
(Campbell 1994, Dilworth 1994). Shc consists of three isoforms of 46, 52, and 66 kDa
(Pelicci 1992). Shc is phosphorylated on tyrosines 239/240 as well as on tyrosine 313
(Salcini 1994, Gotoh 1996). Grb2 binds to Shc at either of the phosphorylated tyrosine
sites and associates with Sos1 or Gab1 (Nicholson 2001). Sos1 is a guanine nucleotide
exchange factor that converts inactive Ras-GDP to active Ras-GTP resulting in the
activation of Raf and the MAP Kinase signaling pathway. Gab1 is involved in the
localization of Sos1 to the cell membrane where it can interact with Ras-GDP (Yamasaki
2003).
Investigation into the role phosphorylation of middle T at tyrosine 322 plays
revealed the amino acids immediately downstream of tyrosine 322 (Leu323-Asp324Ile325) constituted a common binding target of the SH2 domain of Phospholipase C
gamma 1 (PLC-γ1). Immunoblotting of middle T immunoprecipitates with anti-PLC- γ1
antibody showed the presence of PLC-γ1 in a manner dependent on the presence of
tyrosine 322 (Su 1995). This association allows for PLC-γ1 to be phosphorylated by
pp60c-src, which is necessary to activate PLC-γ1 function. PLC-γ1 catalyzes the
hydrolysis of phosphatidylinositol 4,5-bisphosphate into inositol 1,4,5-trisphosphate (IP3)
and diacylglycerol (DAG), each of which activates calcium release and Protein Kinase C
(PKC) respectively (Majerus 1990).
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iii. Small t antigen
The small tumor antigen is nearly identical to the N terminal region of middle T
and differs only by 4 amino acids downstream of the splice site that terminate on a
different reading frame. Like middle T, polyoma small t binds to the A and C subunits of
protein phosphatase 2A (Pallas 1990, Walter 1990). Despite both containing the same
PP2A binding sequence, small and middle T antigen produce different effects when
binding PP2A. Small t antigen was shown to produce cell cycle progression by
associating with PP2A. When middle T mutated in its ability to associate with PI3K and
Shc was expressed, it was unable to promote cell cycle progression despite retaining a
wild-type PP2A association (Mullane 1998). Expression of both small and Large T
antigens results in the induction of S-phase and an increase in cyclin A and cyclin Especific protein kinase activity. Small t antigen mutated in its ability to associate with
PP2A was unable to prevent the protein p27Kip1 from inhibiting cyclin E-specific activity
(Schuchner 1999). Small t is also involved in overcoming p53 dependent growth arrest
and apoptosis. While Large T antigen does not bind p53 directly in polyomavirusinfected cells, small and middle T antigens have been shown to resist apoptosis in p53induced cells through PP2A and PI3K respectively (Qian 2000). In mouse primary cells
and rat embryonic fibroblasts, middle T expression is sufficient to activate the ARF-p53
pathway (Lomax 2001) but coexpression of small t with an intact PP2A binding site is
sufficient to overcome the effects of p53 to produce a transformed phenotype (Moule
2004). Polyomavirus small t and a mutated form of middle T that does not localize to the
cell membrane (and thus cannot interact with Src family kinases) both activate the MAP
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kinase cascade via PP2A in a manner independent of Shc-Grb-Sos activation of Ras
(Rodriguez-Viciana 2006). The hyperacetylation of viral chromatin also depends on
small t directing the host cell to S phase during viral chromosome synthesis and
packaging (Dahl 2007).

B. Polyoma Virus Life Cycle
1. Virus Attachment and Entry
The life cycle of polyomavirus begins with the attachment of the VP1 viral coat
protein to the sialic acid component of the ganglioside surface receptors GD1a and GT1b
on the target host 3T3 cell membrane (Chen 1997, Tsai 2003). The attachment of VP1 to
the cell initiates a signal transduction cascade resulting in an initial increase in the
expression of genes like c-myc and c-fos to prime the cell for DNA replication (Zullo
1987). The virus particles enter the host cell through smooth monopinocytic vesicles and
localize to early endosomes and the endoplasmic reticulum (Griffith 1984, Richterova
2001, Mannova 2003, Liebl 2006). Once it arrives in the ER, the hydrophobic C terminal
domain of the capsid protein VP1 is exposed by the actvity of ERp29, allowing the virus
to cross the ER membrane into the cytoplasm or nucleus (Magnuson 2005). The
chaperone protein Hsp70 is involved in the disassembly of the virus, removing all of the
coat proteins except the VP1 proteins associated directly with the viral genome in a
manner similar to histone H1 (Chromy 2006). The remaining VP1 proteins are necessary
to direct the viral chromatin to the nucleus via their nuclear localization signals (Li P
2001). The protein PARP-1 removes the remaining VP1, revealing the viral enhancers
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and promoters and allowing for the transcription of the early genes to begin (Carbone
2006).

2. Early Phase
Once transcription of the viral genome begins the virus expresses primary
transcripts from both strands with efficient transcription termination at the overlapping
polyadenylation sites (Hyde-DeRuyscher 1988, Gu 2009). This causes the transcripts on
the late strand to destabilize because the late leader exon at the 5’ end of the late region
requires at least one read-through of the entire viral genome to splice properly (Adami
1989, Hyde-DeRuyscher 1990). The early strand primary transcripts are alternatively
spliced to make mRNAs for the Large T, middle T, and small t antigens, which localize
to the nucleus, plasma membrane, and nucleus plus cytoplasm, respectively (Soeda 1980,
Zhu 1984).
The N terminal region of the Large T antigen binds to the Retinoblastoma family
of tumor suppressors including pRb, p107, and p130, causing the release of E2F
transcription factors which control the expression of cell cycle genes (Dyson 1990, Pilon
1996, Desjardins 1997). This interaction is believed to be facilitated by the DnaJ domain
that interacts with host DnaK chaperone proteins like Hsc70 (Cheetham 1992, Sheng
1997). This domain is common to all three T antigens but is primarily utilized by Large
T. Large T also associates with the proteins p300/CBP that function as histone
acetyltransferases and transcriptional coactivators that bind to cell cycle transcription
factors such as the Cyclic AMP Response Element Binding protein (CREB) and facilitate
the recruitment of the transcription complex to express cell cycle genes (Arany 1994,
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Arany 1995, Eckner 1994, Lundblad 1995, Nemethova 1999). In addition to promoting
cell cycle gene expression, Large T also binds to the tumor suppressor p150Sal2, which is
involved in inhibiting DNA replication by activating the transcription of downstream
targets of p53 such as p21 and BAX (Li 2004).
Middle T antigen localizes to the cell membrane and functions as a consitutively
active receptor tyrosine kinase to activate signaling cascades resulting in the host cell
acquiring a transformed phenotype. The N terminal region of middle T binds to the A
and C subunits of protein phosphatase 2A by mimicking the B subunit (Pallas 1990,
Walter 1990). This association allows for middle T to be phosphorylated by pp60c-src
(Courtneidge 1983) at a number of locations including tyrosines 250, 315, and 322
(Harvey 1984, Hunter 1984, Schaffhausen 1981). Once these sites are phosphorylated
they become functional binding sites for a number of major signaling proteins.
Phosphorylation of tyrosine 250 allows for the binding and phosphorylation of Shc
leading to the activation of the MAP kinase cascade (Campbell 1994, Dilworth 1994).
Phosphorylation of tyrosine 315 allows for the binding of the 85kDa subunit of
phosphatidylinositol-3-kinase (Talmage 1989). This results in phosphorylation of
phosphatidylinositol leading to activation of PDK1 and subsequently, Akt resulting in
survival and proliferation (Meili 1998). The phosphorylation of tyrosine 322 allows for
the binding and phosphorylation of PLC-gamma, activating its catalytic function causing
it to cleave PIP2 into IP3 and DAG leading to the release of calcium and the activation of
Protein Kinase C and downstream oncogenes (Su 1995). It is the sustained combined
activation of these pathways that give the cell its transformed phenotype.
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Small t antigen functions, primarily, by binding to PP2A in a manner similar to
middle T (Pallas 1990, Walter 1990). Unlike middle T, small t localizes to the cytoplasm
and nucleus allowing for more direct association with PP2A and any targets not bound to
the cell membrane. While the precise mechanism of action is unclear, the association of
small t antigen with PP2A affects a number of cell processes such as promoting cell cycle
progression (Mullane 1998, Rodriguez-Viciana 2006) and interfering with tumor
suppressors such as p53 (Qian 2000, Moule 2004) or p27Kip1 (Schuchner 1999).
The combined activity of the three T antigens results in the host cell entering S
phase and the activation of host transcription factors results in the expression of proteins
required for the virus to replicate. The C terminal region of Large T binds directly to the
viral genome at the noncoding control region between the origin of replication and the
early transcription start site (Cowie 1984, Dilworth 1984). Large T antigen facilitates
replication of the viral genome by recruiting host replication factors and functioning as a
hexameric DNA helicase (Wang 1991).

3. Early-Late Switch
Once the host enters S phase and viral DNA replication occurs the virus
undergoes an early-late switch where the expression of late-strand transcripts increases
more than 50 fold relative to early-strand transcripts (Kamen 1975, Piper 1979, HydeDeRuyscher 1988). The onset of viral DNA replication correlates with an increase in Ato-I editing of viral RNA by a class of enzymes called Adenosine Deaminase Acting on
RNA (ADARs) (Gu 2009). ADAR enzymes are abundant nuclear and cytoplasmic
proteins that bind double-stranded RNAs with a preference for A-rich regions and
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catalyze a deaminating reaction that alters adenosine bases to inosines (Bass 2002). The
polyadenylation signals (AAUAAA) of polyoma early and late transcripts overlap
completely resulting in A-rich regions on both strands when they hybridize. Whether
hybridization occurs between transcripts from the same or different DNA molecules is
unknown but appears to be dependent on viral DNA replication (Liu 1993). It is the
editing of the polyadenylation signal that is hypothesized to result in a loss of
polyadenylation efficiency leading to the giant transcripts observed at late times
(Acheson 1971, Gu 2009).
While the 3’- and 5’-splice sites flanking the late-leader exon are strong, the 3’ splice
sites for VP3 and VP1 are weaker. This makes leader-to-message body splicing
relatively inefficient, thus favoring the stronger leader-to-leader splicing in multigenomic
length precursors (Batt 1994). The loss of polyadenylation efficiency results in an
approximately 50% chance a given transcription complex will terminate resulting in the
observation of primary transcripts as large as 12-15 times the length of the viral genome
(Acheson 1984, Hyde-DeRuyscher 1990). Splicing priority is given to the 3’ splice site
of the late leader resulting in all of the full genome introns between late leaders being
spliced out and only the last 5’ splice site splices to form VP1 or VP3, or retains the
intron to form VP2. This process yields VP1, VP2, or VP3 mRNAs with a number of
tandem repeats of the late leader sequence corresponding to the number of times the
transcription complex read through the polyadenylation site before terminating (Fig. 5)
(Hyde-DeRuyscher 1990). Interestingly, while the late leader exon itself contains
sequences complementary to the 3’ end of mouse 18S ribosomal RNA (Soeda 1980) as
well as binding sites for the 40S ribosomal subunit (Legon 1979A), the actual sequence
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appears dispensable for virus viability and predominantly serves as a spacer (Adami
1986). When the sequence of the late leader was replaced with a different sequence
lacking complementarity to the mouse 18S ribosomal RNA, it showed no difference in
translational efficiency (Rhee 1989).
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Figure 5. Leader-to-leader splicing

During the late phase of infection, the efficiency of polyadenylation decreases leading to
the production of giant multigenome-long transcripts. The late mRNAs for VP1, VP2,
and VP3 require the late leader exon to splice across the entire genome length introns at
least once to prduce stable mRNAs. The number of late leaders in a given mRNA
corresponds to the number of times the polyomerase went around the genome.
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4. Late Phase
During the late phase of infection the host cell is rapidly dividing, even at low
serum concentrations. After the onset of viral DNA replication late-strand transcripts
accumulate rapidly and can constitute up to 2% of all the transcripts in the cell (Kamen
1975, Piper 1979, Hyde-DeRuyscher 1988). The late genes VP1, VP2, and VP3 are
expressed at 50 to 100 times the level of early genes and the giant transcripts from both
strands have the potential to hybridize, resulting in hyper-editing by ADAR across the
entire viral transcriptome (Gu 2009). This likely interferes with the early transcripts
more than the late transcripts because of the multiple genome long introns spliced out of
late pre-mRNA that are not spliced from the early strand. These giant introns potentially
reduce the chances of spliced late mRNA being edited compared to early transcripts.
VP1 localizes to the nucleus and assembles into viral capsids in a manner
dependent on calcium activation (Salunke 1989, Montross 1991). This calcium
dependence could be part of the reason defects in VP1 encapsidation were observed in
middle T mutants (Garcea 1989). If the mutants were unable to properly interact with
PLCγ and trigger a downstream calcium release, it could have affected VP1 assembly.
VP2 and VP3 require the presence of VP1 to localize to the nucleus (Delos 1993).
VP1 and VP2 are able to associate with each other in the cytoplasm and utilize the
nuclear localization signal of either protein (Cai 1994). All three late proteins are
translated in the cytoplasm and associate with Hsc70 before localizing to the nucleus
(Cripe 1995). This association is likely necessary to prevent premature capsid assembly
in the cytoplasm. VP1 alone is sufficient to assemble ~5kb of DNA into capsids (Gillock
1997). VP1, but not VP2 or VP3, binds directly to DNA through the same N terminal
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region that contains the nuclear localization signal in a manner independent of sequence
(Chang 1993). The encapsidation of DNA is dependent on the concentration of viral
genomes and not on any particular sequence (Spanielova 2014).

5. Host Cell Lysis
By 72 hours after the initial infection, 46% of the host cells are necrotic while
10% are apoptotic (An 2000). This is unsurprising because of the continued expression
of early gene products that interfere with a number of apoptotic pathways. The small
population of apoptotic cells is potentially the result of the minor viral coat proteins VP2
and VP3, which have been shown to induce apoptosis when transfected directly
(Huerfano 2010). Once the host cell lyses, virus is released and the process starts over
with attachment to the next host.
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C. Thesis Objective and Specific Aims

The goal of this thesis is to describe global changes in transcription observed by
high throughput illumina sequencing of the total RNA from a polyoma infection.
Historically polyomavirus has proven invaluable for understanding host tumorigenesis
through interaction of viral factors with mitogenic pathways. The virus has also allowed
for understanding of host transcription and replication factors due to its small size.
Despite this, a global view of transcription during polyoma infection has yet to be
observed. By aligning sequencing reads from either different time points during infection
or from infected cells treated with or without a DNA replication inhibitor, our lab can
observe RNA from early and late phases of infection from both the virus and host. In
addition, the use of new read sorting pipelines allows for more direct observation of
hyper-editing predicted from the production of viral giant transcripts from both strands at
late times that was once difficult to observe using conventional methods. By seeing the
changes in viral and host transcription, we can discover new aspects of viral gene
regulation as well as downstream host effects.

Specific Aim I: Investigate changes in transcription, splicing, and editing of the viral
transcriptome at a global level
Traditional methods of investigating changes in viral RNA expression over the
course of infection are costly, labor intensive, and have a limited scope. By using next
generation sequencing to simulteneously observe changes in viral transcripts across the
viral genome, it becomes possible to achieve a more global view of processes such as
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transcription, splicing, and editing. The Illumina TruSeq Stranded sequencing system
allows for the creation of strand specific libraries to be sequenced at a depth of over 50
million reads. These reads can then be aligned to the viral genome to illustrate the total
RNA expression levels at both early and late phases of the viral life cycle. Furthermore,
reads spanning splice junctions can be used to observe any changes in the relative
abundance of viral isoforms on each strand. Finally, using a pipeline recently developed
by Porath et al (2014), we can sort unaligned reads to find clusters of mismatches with a
high probability of resulting from A-to-I editing that has been predicted for polyoma
transcripts but only observed in a limited way.

Specific Aim II: Investigate global changes in coding and noncoding host transcripts
over the course of a mouse polyomavirus infection.
Viral proteins, especially the T antigens, have been demonstrated to show a
number of significant mitogenic effects on host gene expression. These mitogenic effects
result in a number of transcription factors involved in cell cycle control being activated to
transition the host cell into S phase and initiate DNA replication. The same sequencing
approach used for viral transcripts can also be used to observe changes in all of the
detectable host genes simultaneously. By aligning reads from total RNA taken from both
infected and uninfected samples at different time points to the mouse genome, we can
observe downstream changes in host gene transcription for both coding and noncoding
RNA. Both upregulated and downregulated genes can be analyzed based on enrichment
for common functions as well as predicted transcription factor binding sites to determine
the types of categories being overrepresented. This allows for a much broader look at the
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over all changes in the virus infection than could ever be achieved through traditional
targeted methods.
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II. MATERIALS AND METHODS

A. Cell Culture and Virus Infection
NIH 3T6 mouse fibroblast cells were cultured on 10 cm plates at a density of
600Kcells/plate in Gibco Dulbecco’s Modified Eagle Medium (11995-065) supplemented
with 100 units of penicillin/streptomycin, 2mM L-Glutamine, and 5% calf serum. Cells
were serum starved in 2% calf serum 1 day before infection to synchronize cell cycles.
Polyomavirus strain Py59RA was generously provided by Dr. Robert Garcia in 2%
Medium at 180 million plaque forming units per ml. Virus was diluted to 15 million
PFU/ml to infect cells at an MOI of 50 using 2 ml of virus per plate. Cells were infected
by removing media and adding 2 ml of virus for 2 hours before being supplemented with
8ml of 2% media at time point 0. Mock infections were carried out using 2% medium
without filtered virus particles. Total RNA was harvested at 12, 18, 24, and 36 hours
after infection by removing media, washing with PBS, and adding 4M guanidinium
isothiocyanate. For the aphidicolin treated samples, cells were plated at the same density,
treated with the same media, and infected at the same MOI for 40 and 48 hours.
Aphidicolin positive cells were treated with media containing 2µg/ml aphidicolin.

B. Preparation of TruSeq™ Stranded Library
RNA was isolated by cesium centrifugation through 2 ml of 5.7M cesium chloride
at 39000 rpm at 20°C for 18 hours and DNAse treated with DNAse 1 from the Ambion
DNAse I Kit. 1 µg of RNA was used from each sample for library preparation with the
Trueseq Stranded Total RNA kit from Illumina. Ribosomal RNA was depleted using

52	
  

	
  
rRNA binding beads and the RNA was fragmented and primed with random hexamers.
First strand synthesis was done using a mixture containing Superscript II and
Actinomycin D to synthesize RNA dependent DNA and inhibit DNA dependent RNA
respectively. Second strand synthesis was done using dUTP instead of dTTP to create
stranded cDNA. Libraries were then adenylated at the 3’ end and adaptors containing
identifier sequences and flow-cell binding sequences were ligated to both ends. Finally
the cDNA fragments were amplified for 12 cycles instead of 15. The Agilent
Technologies 2200 Tapestation was used to verify library size at ~260bp. Sequencing
was done on a HiSeq 2000 by Perkin Elmer.

C. Analysis
All alignments were made using Tophat v 2.0.9, Bowtie 2.1.0, and Samtools 1.19.
Alignments to polyoma were done using the reference genome for the Py59RA strain of
polyomavirus for both time course and aphidicolin experiments. Time course
experiments consisted of four conditions, for mock infection and four conditions for
polyoma infection representing 12, 18, 24, and 36-hour time points with three biological
replicates per condition. Aphidicolin experiments consisted of two conditions Aphi+ and
Aphi- with two biological replicates.
Alignment of timecourse reads to the host genome was done using the reference
genome from Illumina’s IGENOMES collection, which in turn was taken from USCS
March 5, 2013. The annotation file was modified to remove single-base exons due to
difficulties tophat had in processing them. Custom scripts were used to postprocess
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tophat output to produce strand-specific bedGraph files suitable for use on the UCSC
genome browser.
Alignment of reads to the viral origin was done using a custom script that rotated
the genome zero position counterclockwise by 149nt to avoid splitting annotated
transcripts. The reads were aligned to the “rotated” reference genome using tophat with a
new bowtie index and transcriptome index. A custom script was then used to convert the
new alignments to the original coordinates and the new alignments were added to the
original alignments and displayed on the UCSC genome browser.
Alignment of reads containing tandem repeats of the late leader exon from late
gene mRNAs that would not align to the viral genome directly was accomplished by
doing a direct Bowtie1 end-to-end alignment to predefined reference sequences allowing
for up to 2 mismatches. Three references contained 42 bases of the 5’ UTR of VP1, VP2,
or VP3 followed by the 57 base late leader exon and the first 42 bases of the next late
leader. One reference contained the last 42 bases of the late leader followed by a full 57
base late leader followed by the first 42 bases of the transcription start region upstream of
the late leader exon. The last reference sequence contained a full 57 base late leader
flanked by 42 bases of each late leader on either side. This allowed 100-base reads
spanning at least one leader-to-leader splice junction that would not align more than once
to the same reference sequence to align.
A to G mismatches were identified using custom scripts that split the fastq reads
into smaller 25nt fragments and filtered out any that could align to the mouse genome.
The remaining fragments were aligned to the Py59RA genome using Bowtie1, allowing
for up to 3 mismatches. Another custom postprocessing script was used to interpret

54	
  

	
  
bowtie alignment output format and scan mismatch fields for canonical editing
substitutions.
The hyper editing scripts from Porath et al. 2014 were downloaded and run in the
context of our cluster pipeline. Custom scripts were used to extract infromation from
output files, summarize, and plot as tracks on the UCSC genome browser.
The relative expression of host genes between time course Mock and PyV
infected samples was determined using Cuffdiff v 2.1.1. Dispersion method pooled and
dispersion method per condition were used to compare individual replicates and all
replicates of a given condition. Custom scripts were used to post process/ filter cuffdiff
output to produce time-series instances of significant logFoldchange. Cluster 3.0 was
used to produce a k-means clustering of time course gene expression. Genes with a log2
fold change of +/-0.75 representing a 1.5 fold change with an fpkm greater than or equal
to 1 were used for gene ontology and transcription factor prediction.
Gene ontology analysis was done using the browser-based application DAVID
(Database for Annotation, Visualization, and Integrated Discovery)(
http://david.abcc.ncifcrf.gov/home.jsp). Gene lists of upregulated and down regulated
genes were each run against a Mus musculus background and gene categories with a false
discovery rate below 1E-03 were used with redundant categories removed.
Transcription factor binding prediction was done using the browser-based application
Transfind (http://transfind.sys-bio.net/). The same gene lists of up and down regulated
genes were used with a 1000nt promoter set (800nt upstream and 200 nt downstream
TSS) with 1000 genes with the highest predicted factor afinities to take. The TRANSFAC
(highest info content for each factor) setting was used to represent the factors.
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III. RESULTS

A. RNA expression in NIH 3T6 cells infected with the Py59RA strain of mouse
polyomavirus.
Mouse NIH 3T6 cells were serum starved to partially synchronize their cell cycles
and then infected without (mock infection) or with filtered Py59RA virus (PyV) at a
multiplicity of infection of 50. Total RNA was harvested at 12, 18, 24, and 36-hours post
infection from three biological replicates for each condition and was used in the synthesis
of stranded cDNA sequencing libraries using the Illumina TruSeq Stranded Total RNA
Sample Preparation Kit. This resulted in libraries ~260 base pairs in length (Fig. 6). The
libraries were sequenced using the Illumina HiSeq 2000 platform using paired end reads
of 100 bases in the forward and reverse directions. Sequencing data were aligned using
TopHat and normalized transcript abundance was calculated in fragments per kilobase of
exon per million fragments mapped (FPKM) using Cufflinks. Significant differences
between the virus and mock infections at each time point were determined using Cuffdiff.
Each condition had three biological replicates producing 10-50 million 100 base reads
with close to 80% aligning to the host genome and over 1% aligning to the viral genome
by 36 hours post infection (Table 1).
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Figure 6. Library Sizes

Libraries used for sequencing were run on Agilent Technologies 2200 Tape Station to
verify library size. Libraries were made from 3 biological replicates of mock and PyV
infected samples at 12, 18, 24, and 36 hour time points. The average size of the libraries
was 260 bases.
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Table 1. Viral RNA splicing events during infection

Number of aligned reads spanning viral splice junctions during the time course across
three biological replicates. Percentages shown are with respect to total early or total late
splice junction alignments
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Mock 12_1
Mock 12_2
Mock 12_3
Py 12_1
Py 12_2
Py 12_3
Mock 18_1
Mock 18_2
Mock 18_3
Py 18_1
Py 18_2
Py 18_3
Mock 24_1
Mock 24_2
Mock 24_3
Py 24_1
Py 24_2
Py 24_3
Mock 36_1
Mock 36_2
Mock 36_3
Py 36_1
Py 36_2
Py 36_3

Total
Reads
43,640,510
13,407,044
20,726,081
44,588,864
21,230,860
22,857,265
43,100,950
15,771,155
12,835,580
43,139,743
26,910,215
14,252,449
40,147,080
21,984,888
21,103,516
50,787,902
23,365,973
22,087,645
44,049,053
20,282,845
16,873,257
41,028,401
16,629,665
9,748,905

Paired Alignment to
Mouse Genome
34,532,713 (79.1%)
10,084,100 (75.2%)
14,381,090 (69.4%)
33,353,378 (74.8%)
18,103,847 (85.3%)
18,115,603 (79.3%)
33,496,251 (77.7%)
12,276,902 (77.8%)
9,826,513 (76.5%)
32,662,054 (75.7%)
21,803,365 (81.0%)
10,824,627 (75.9%)
32,936,666 (82.0%)
16,516,224 (75.1%)
16,094,651 (76.3%)
40,004,936 (78.8%)
18,637,909 (79.8%)
17,404,983 (78.8%)
35,120,311 (79.7%)
17,153,722 (84.6%)
9,811,783 (58.2%)
28,135,319 (68.6%)
11,053,515 (66.5%)
5,795,074 (59.5%)
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Paired Alignment
to Polyomavirus
Genome
1,710 (<0.01%)
1081 (<0.01%)
1239 (<0.01%)
96,334 (0.22%)
44,146 (0.16%)
29,203 (0.20%)
612,197 (1.2%)
356,237 (1.52%)
409,726 (1.86%)
600,650 (1.46%)
314,095 (1.89%)
198,156 (2.03%)

	
  
B. The polyomavirus transcriptome.
In order to visualize changes in viral transcripts at different time points during
infection, we used Bowtie and Top Hat to align sequencing reads to a Py59RA reference
genome (Fig. 7). At 12 hours after infection, reads mapped to both early and late strands,
but with most representing early-strand expression. While this is consistent with a model
where the early promoter dominates before the onset of viral DNA replication (Kern
1986), it could also be consistent with a model in which the early-late switch is dependent
on relative transcript stability rather than on regulation of transcription initiation (HydeDeRuyscher 1988). By 18 hours after infection viral replication has commenced and the
infection is entering the late phase. At this point, there is an approximate 100-fold
increase in reads aligning to the late strand and these transcripts are beginning to
dominate over early-strand transcripts (Fig. 8). Also of note at this time is the appearance
of a significant number of transcripts that extend beyond the late polyadenylation site,
representing multi-genomic late-strand transcripts (Acheson 1971, Gu 2009). While most
fully polyadenylated and spliced late RNAs are cytoplasmic (Kamen 1976, Acheson
1978), these giant RNAs are nuclear and serve as precursors to late mRNAs (Turler 1976,
Flavell 1977, Acheson 1978). By 24 and 36 hours after infection the number of late
strand alignments increases to around 1000 fold compared to early times. We note that at
late times the majority of fully processed viral mRNAs have accumulated in the
cytoplasm (Kamen 1975, Beard 1976, Hyde-DeRuyscher 1990).
While the relative levels of early-strand and late-strands change dramatically
during infection, we noted no significant changes in patterns of RNA splicing, but did
observe several interesting and unexpected changes to early-strand RNA accumulation
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Figure 7. Py59RA reference sequence

5‘ splice sites are indicated in blue. 3‘ Splice sites are indicated in red. The late leader
exon is shown with the black box. The early poly(A) site shown with a blue box. The
complement of the late poly(A) site is shown with a red box.

62	
  

	
  

63	
  

	
  
Figure 8. Alignment of the time course reads to the Py59RA genome (unscaled)

NIH 3T6 cells were infected with Py59RA at an MOI of 50 or with a mock infection.
Total RNA was harvested at 12, 18, 24, and 36 hours and stranded cDNA libraries were
prepared for sequencing on the HiSeq 2000 sequencer. Reads were aligned to the
Py59RA genome and visualized on the UCSC genome browser. Time course reads
aligned to the Py59RA genome unscaled to show differential expression between early
(top blue) and late (bottom red) strands.
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during infection. First, it is clear that, relative to the bulk of early-strand RNAs, there is
elevated alignment to a roughly 200 base pair region just downstream of the early
polyadenylation site (Fig. 9). This peak was not seen when DNA replication and the
early-late switch is blocked by aphidicolin (Fig. 10). In this experiment, mouse NIH3T6
cells were infected with Py59RA virus in the same manner as the time course except they
were treated with either the same media or media with 2 µg/ml of the DNA replication
inhibitor aphidicolin to prevent the infection from entering the late phase (Liu 1993).
The infected samples, both treated and untreated, were incubated for 40 and 48 hours
before RNA was collected for stranded cDNA library synthesis using the same protocol
as the time course. This allowed sufficient accumulation of early gene products without
the untreated samples reaching the lysis phase of the viral life cycle. Results were only
aligned to the viral genome since aphidicolin treatment would likely cause significant
alterations to the host transcriptome.
These reads appear to result from poly(A) site read-through and are antisense to
VP1. While we do not yet know why or how they accumulate, one possible explanation
would be that they represent precursors for viral-encoded microRNA(s). Polyomavirus
and SV40 have previously shown viral expression of microRNAs antisense to Large T
antigen, which were hypothesized to help avoid a cytotoxic T cell response (Sullivan
2005, Sullivan 2009). Alternatively, the increase in sequences from this region could
result from uneven processing/degradation of early-strand transcripts that have read
through the early polyadenylation site.
The second unexpected change in early-strand RNA alignments during infection
is in the early promoter/origin/noncoding control region. We originally noted changes in
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Figure 9. Alignment of the time course reads to the Py59RA genome (scaled)

NIH 3T6 cells were infected with Py59RA at an MOI of 50 or with a mock infection.
Total RNA was harvested at 12, 18, 24, and 36 hours and stranded cDNA libraries were
prepared for sequencing on the HiSeq 2000 sequencer. Reads were aligned to the
Py59RA genome and visualized on the UCSC genome browser. Time course reads
aligned to the Py59RA genome scaled to show changes in early strand alignment. Top
blue strand is early, bottom red is late. The transcription start site can be seen shifting
across the origin to the far right on the early strand. In addition a peak can be seen on the
early strand downstream of the polyA site in the center between 3200 and 3500 bases.
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Figure 10. Alignment of 48 hour aphidicolin + and - reads to Py59RA genome.

NIH 3T6 cells were infected with Py59RA at an MOI of 50 or with a mock infection and
treated with or without the DNA replication inhibitor aphidicolin at a concentration of
2µg/ml (5.9µM). Total RNA was harvested at 48 hours and stranded cDNA libraries
were prepared for sequencing on the HiSeq 2000 sequencer. Reads were aligned to the
Py59RA genome and visualized on the UCSC genome browser. (A) Samples of 48 hr
infections with and without the DNA replication inhibitor aphidicolin to block the
initiation of late phase aligned to the Py59RA genome unscaled to show differential
expression between early and late strands. (B) Scaled to show changes in early strand
alignment.
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alignments to the edges of our reference genome. By aligning the reads to a linearized
reference genome shifted by about 150 bp, we were better able to visualize the nature of
these molecules, which span the replication origin. As infection proceeds, there is a clear
increase in the alignment of early-strand reads to the origin of replication and enhancer
region, strongly suggesting a potential upstream shift in early-strand transcription start
sites during infection, and particularly after the onset of viral DNA replication (Fig. 7).
We note that even at late times after infection in the aphidicolin treated samples, this shift
is not observed (Fig. 8). Such a shift from a strict early transcription start site
downstream of a canonical TATA box at early times (e.g., the 12 hour time point) to
variable upstream transcription start sites at late times was suggested previously to
explain confounding results obtained by S1 nuclease experiments (Kamen 1982).
Mapping of the hybridization of 5’ ends of cytoplasmic early-strand transcripts at late
times to a region of the polyoma genome containing the noncoding control region and
part of the early region showed an apparent increase in usage of upstream start sites
(Kamen 1982).

C. Splicing analysis
Using TopHat to map the splice junction reads we were able to determine the
relative expression levels of the 5 viral isoforms that contain splice junctions (Table 2).
At 12 hours post infection the mRNA for large T represents 75% of early-strand mRNAs,
with mRNAs for middle T and small t accounting for 20% and 5%, respectively. We also
note that a fourth early mRNA, for “tiny T antigen” encoding just the DnaJ domain
(Riley 1997) has been reported and this is seen in our data, although this message is of
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Table 2. Viral splicing events during infection

Number of aligned reads spanning viral splice junctions during the time course across
three biological replicates. Percentages shown are with respect to total early or total late
splice junction alignments.
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Large T

middle T

small t

tiny t

VP1

VP3

50
(75.8%)
40
(74.1%)
72
(87.7%)

13
(19.7%)
9
(16.6%)
8
(9.8%)

3
(4.5%)
5
(9.3%)
2
(2.5%)

0
(0%)
0
(0%)
0
(0%)

46
(88.5%)
20
(80%)
12
(80%)

6
(11.5%)
5
(20%)
3
(20%)

589
(62.9%)
354
(69.3%)
250
(69.6%)

175
(18.7%)
82
(16%)
58
(16.2%)

172
(18.4%)
75
(14.7%)
51
(14.2%)

0
(0%)
0
(0%)
0
(0%)

2735
(89.6%)
1058
(77.3%)
863
(80.9%)

319
(10.4%)
311
(22.7%)
204
(19.1%)

1686
(64.2%)
788
(63.1%)
1074
(65.1%)

559
(21.2%)
237
(19%)
306
(18.5%)

380
(14.4%)
218
(17.4%)
262
(15.8%)

6
(0.2%)
7
(0.5%)
10
(0.6%)

41245
(90.2%)
14203
(80%)
17825
(79.6%)

4133
(9.1%)
3553
(20%)
4570
(20.4%)

1822
(63.7%)
630
(59.5%)
408
(60.6%)

589
(20.6%)
250
(23.6%)
162
(24%)

442
(15.4%)
169
(16%)
97
(14.4%)

10
(0.3%)
10
(0.9%)
7
(1%)

39525
(90.2%)
16453
(78.3%)
11087
(80.1%)

4294
(9.8%)
4555
(21.7%)
2760
(19.9%)

12 Hours
Rep 1
Rep 2
Rep 3
18 hours
Rep 1
Rep 2
Rep 3
24 Hours
Rep 1
Rep 2
Rep 3
36 hours
Rep 1
Rep 2
Rep 3
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very low relative abundance. As infection proceeds, the ratios of large, middle and small
T antigen mRNAs change little, indicating that early strand splicing is likely not
regulated strongly by viral or host proteins that change during infection. Like early
mRNAs, late splicing patterns do not change dramatically during infection, although the
absolute numbers of alignments increase up to 1000 fold, consistent with the strong
upregulation of late gene expression.

D. Leader-to-leader splicing.
Owing to the presence of tandem repeats of late leaders in all three late mRNAs,
alternative reference sequences were required to capture reads that span at least one
leader-to-leader splice junction (Table 3). The stranded cDNA libraries produce 2x100
base pair reads. The late leader exon is 57 bases long so we required a reference
sequence that captured reads that extended at least 1 base past the first leader-to-leader
splice junction both downstream and upstream of the late leader on VP1, VP2, and VP3
cDNA as well as the late transcription start sites. We used a reference sequence
containing 42 bases upstream of the late leader exon near the transcription start region
followed by a full late leader exon and the first 42 bases of the next late leader (Table 3
bottom of first column). We also used a reference sequence of the last 42 bases of late
leader, a full late leader, and the first 42 bases of late leader to capture ambiguous leader
to leader reads from any mRNA crossing at least 2 leader to leader splice junctions
(Table 3 bottom of second column). Reference sequences containing the last 42 bases of
a late leader followed by a full late leader and 42 bases of the 5’ UTR of VP1, VP2 or
VP3 (Table 3 bottom of third, fourth, and fifth columns). Leader-to-leader splices were
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Table 3. Alignment of reads from late leader repeats.

The 100 base reads from time course and aphidicolin samples were realigned to custom
reference sequences containing at least one leader to leader splice junction. The
reference sequences were 5 variations of a 42-57-42 base splice of late leader exons to
each other, the transcription start site, or the 5‘UTR of VP1-3. The number of reads
aligning to each reference sequence for each condition is shown.
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only seen at significant levels in time points later than 18 hours and in cells untreated
with aphidicolin, supporting the model that leader to leader splicing occurs after DNA
replication.

E. A-to-I editing of viral RNAs.
Due to the read-through of early and late transcripts at late times, as well as the
genomic overlap of the early and late polyadenylation signals, there is the possibility that
if complementary sequences accumulate near one another in the nucleus, they might form
double stranded RNAs. As nuclear dsRNAs can be promiscuously edited by ADAR
enzymes, which deaminate adenosines to inosines (Bass 2002), viral dsRNAs should also
exhibit this fate. We have reported previously that this is indeed the case (Kumar 1997,
Gu 2009), but the current study allowed us to examine viral RNA editing in more
comprehensive detail, which was done in two ways. Since inosine base pairs like
guanosine, we first looked for individual A-G mismatches in the read alignments to
search for potential sites for editing. We divided the 100 nucleotide reads into four 25nucleotide fragments and allowed up to three base mismatches during the alignment step
(Zhu 2013). After filtering for any sequences that aligned to the mouse genome, we
realigned the sequences to the viral genome to show regions of A-G mismatches (Fig.
11). Such alignment cannot be conclusive for RNA editing, as it could merely reflect
sequencing or alignment errors. Indeed, this sort of analysis, when applied to other base
transformations, generated similar, though less robust data. We therefore examined viral
regions where A-G mismatches greatly outnumbered mismatches caused by any other
base changes. The most striking region associated with A-G changes was the
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Figure 11. Reads with up to 3 A-G mismatches as potential ADAR editing sites.

Reads from the time course run were broken from 100 bases to 25 bases and realigned
with a threshold of 3 mismatches allowed per 25 base read. Reads with A-G mismatches
were visualized using the UCSC genome browser to indicate regions with potential
editing sites. The polyadenylation sites showed the highest number of A-G mismatched
reads at late times of infection.
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overlapping polyadenylation region, which showed a much higher rate of A-G mismatch
compared to other combinations (Table 4). This was not surprising since the
polyadenylation region has previously shown to be edited at late times during infection
(Gu 2009).

As long dsRNA is subject to hyperediting, where up to 50% of the adenosines are
converted to inosines (Kumar 1997), it is quite likely that the above analysis missed
much or most of the editing that occurs during polyomavirus infection. In order to
capture a greater fraction of hyper edited reads that may have been omitted due to having
too many A-G mismatches we used a method recently described by Porath et al 2014.
These authors developed a pipeline that sorts unaligned reads based on whether they fail
to align due to a specific type of mismatch and whether such mismatches occur in the
types of clusters associated with hyperediting. The first step was to align all the reads to
the mouse genome to reduce the total number of reads and remove most non-viral
sequences. Second, we aligned the remaining reads to the viral genome and discarded
any that aligned perfectly or with few mismatches. Third, we transformed all As in both
the reads and the reference genome to Gs and discarded any transcripts that did not align.
This allowed us to only sort for reads that initially had A to G mismatches. Fourth, the
mismatches were clustered based on predictions for known A-I editing including adjacent
sequences and only reads that clustered in a manner consistent with A-I editing were
kept. Finally the bases that were members of clusters were displayed on the UCSC
genome browser (Fig. 12). Results showed a time dependent increase in the number of
bases that were members of hyperedited clusters, with a large concentration of such
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Table 4. Single base mismatches across the polyoma genome.

Base to base mismatches from the 36 hour time point found in the 25 base read
alignments allowing for up to 3 mismatches. Mismatches in and around the poly(A) sites
show the highest number of A to G mismatch. Early and late poly(A) sites in bold. Each
position represents both strands.
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Figure 12. Accumulation of hyper-editing clusters during the time course.

Reads from the time course were aligned with the host mouse genome and discarded.
Reads were then aligned to the Py59RA reference genome and discarded. A’s in reads
that did not align to the Py59RA genome were changed to G’s and realigned to a Py59RA
reference genome that itself had all A’s changed to G’s. This allowed for reads that did
not originally align to the unalteredt Py59RA genome due to hyperediting to be captured.
The process was repeated for all combinations of single base mismatch. Clusters of A-G
mismatches from the time course consistent with hyperediting by ADAR were mapped to
the Py59RA genome.
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clusters around the overlapping polyadenylation sites. No significant editing was
detected in aphidicolin treated samples (data not shown). Together, these data are
consistent with our previously reported polyoma editing results (Heiser 1982, Gu 2009).
Shortly after the early late switch at 18 hours we see the polyadenylation region (and a
cryptic poly(A) site in the early region, just downstream of the stop codon for middle T
antigen) showing editing clusters. As the infection progresses the number and size of the
clusters increases on both strands. This is consistent with editing resulting from early and
late strand hybridization since the over abundance of late sequence compared to early
would only produce more clusters if the late strand formed hairpins and was edited in cis.
Editing clusters can also be seen in the noncoding control region suggesting that multigenome length giant transcripts are capable of annealing with one another. While editing
has long been predicted due to the long antisense transcripts and poly(A) read-through,
this is the first time we have had direct evidence of genomewide editing at late times. We
note, however, that while editing is readily and abundantly observed, we cannot conclude
from these data whether it is a cause or a consequence of viral gene regulation.

F. Effects of viral infection on host gene expression.
Our deep sequencing data allowed us to not only examine viral gene expression
during infection, but also changes in the host transcriptome that result from the infection.
Using Cuffdiff to compare gene expression between polyomavirus and mock infected
samples, we found 1,216 genes were differentially expressed at least 1.5 fold across all
three replicates with 359 genes upregulated and 857 genes downregulated compared to
the mock infections at the 36 hour time point (Table 5).
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Table 5. Number of host genes dfferentially expressed between mock and Py59RA
infected samples

The number of host transcripts that changed more than 1.5 fold across all three biological
replicates was determined using Cuffdiff. Only genes with expression >1 fpkm were
counted.
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12 hours

18 hours

24 hours

36 hours

Upregulated

0

6

12

359

Downregulated

0

7

19

857

Total

0

13

31

1,217

87	
  

	
  
We used the database for annotation, visualization, and integrated discovery
(DAVID) (http://david.abcc.ncifcrf.gov/) to determine the gene ontology of the
differentially expressed genes that were significantly enriched based on common
biological function (Table 6). We also selected genes of high abundance with a strong up
or down regulation between mock and virus infected cells at 36 hours for validation by
RT-qPCR (Fig. 13 and 14).
For the upregulated genes the categories with the highest enrichment included
transcripts coding for ribosomal proteins, chromatin binding proteins, DNA replication,
RNA processing, and mitochondrial proteins. These are all consistent with the known
increase in growth and metabolism induced by the combined action of the early genes.
For example, the transcript for Hist1h1a that codes for the histone 1 linker involved in
compacting DNA during replication (van Holde 1988) is upregulated more than 2 fold in
infected cells by 36 hours (Fig. 15). The transcript for the mitochondrial inner membrane
protein Timm8a1 that is involved in the insertion of cytoplasmic proteins into the
mitochondrial inner membrane (Paschen 2000) is also upregulated. Another interesting
observation is the transcript coding for the JunB component of AP-1 transcription factors
is upregulated. This is of interest because JunB was originally understood to function as
an antagonist of the AP-1 protein c-Jun, which is involved in cell cycle progression (Chiu
1989, Schutte 1989). Later observations found this interaction to be more complex and
sensitive to cell type and context (Shaulian 2002).
Downregulated genes were enriched in categories such as GTPase regulation, cell
adhesion, actin cytoskeleton, extracellular matrix, and transcription regulation. One of
the more strongly downregulated transcripts included Col1a2 (Fig. 15) which codes for
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Table 6. Gene ontology analysis
The web based application Database for Annotation, Visualization and Integrated
Discovery (DAVID) was used to sort lists of significantly upregulated or downregulated
genes (>1.5 fold) from the 36 hour time point by common function and enrichment using
the Mus musculus background. A false discovery threshold of 1E-03 was used.
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Upregulated
Ribosomal
Protein
RNA
Processing
Chromosomal
Protein
Mitochondrial
Protein
DNA
Replication
Ribosome
Biogenesis
Pyrimidine
Metabolism
Downregulated
GTPase
Regulator
Cell
Adhesion
Actin
Cytoskeleton
Chromosome
Organization
Embryonic
Development
Transcription
Regulation
Urogenital
Development
Cell
Motion
Extracellular
Matrix
Pathways in
Cancer
Zinc
Finger

Gene
Count

% of
upregulated
genes

P-value

Fold
Enrichment

FDR

38

11.95

3.60E-30

12.86

4.65E-27

31

9.75

3.29E-10

3.9

5.19E-07

19

8.5

1.19E-11

8.37

1.53E-08

42

13.2

9.30E-11

3.18

1.20E-07

18

5.66

2.16E-09

6.51

3.41E-06

14

4.4

1.13E-07

6.87

1.79E-04

16

5.03

1.50E-09

7.59

1.55E-06

58

6.98

1.19E-16

3.49

1.67E-13

61

7.34

8.60E-10

2.35

1.52E-06

32

3.85

7.04E-10

3.66

9.73E-07

44

5.29

2.70E-07

2.36

4.76E-04

48

5.77

1.70E-08

2.47

2.99E-05

158

19.01

8.99E-09

1.53

1.59E-05

27

3.25

2.60E-09

4

4.59E-06

44

5.29

1.73E-08

2.59

3.05E-05

39

4.7

3.69E-09

2.96

5.09E-06

42

5.05

5.53E-10

2.9

6.27E-07

93

11.2

4.90E-08

1.79

6.79E-05
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Figure 13. Validation of upregulated genes.

One noncoding and three coding genes with a high expression and at least 1.5 fold
change were selected for validation of upregulated genes by qPCR. FPKM results shown
in left cloumn. qRT-PCR results shown in the right column.
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Figure 14. Validation of downregulated genes.

One noncoding and three coding genes with a high expression and at least 1.5 fold
change were selected for validation of downregulated genes by qPCR. FPKM results
shown in left cloumn. qRT-PCR results shown in the right column.
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Figure 15. Example of host protein coding transcripts significantly upregulated or
downregulated in infected samples compared to mock infection.

Protein coding reads from the time course were aligned to the host genome. (Left)
Expression of Hist1ha increases compared to mock infection. (Right) Col1a2 decreases
compared to mock infection.
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one of the polypeptide components of Collagen type 1 that makes up the extracellular
matrix (Vuorio 1990). Another strongly downregulated transcript encodes the steroylCoA desaturase 2 (Scd2) enzyme that catalyzes the synthesis of monounsaturated fatty
acids, increasing membrane fluidity (Ntambi 1999). Unlike in polyoma infection, Scd2
has been shown to be upregulated in other cancer cells and may be responsible for
inducing hepatocellular carcinomas (Muir 2013). It is unclear how the virus would
benefit from a reduction in monounsaturated fatty acid synthesis. The transcript for the
protein myristolylated alanine-rich C-kinase substrate (Marcks) that is involved in
altering the actin cytoskeleton (Laux 2000), cell motility (Brooks 1996), and functions as
a tumor suppressor (Bickerboller 2015) was originally shown to be downregulated in
mouse 3T3 fibroblast cells expressing v-Src (Joseph 1992). Our data also show
significant down regulation of this transcript.
In addition to coding RNAs, we observed significant changes in the expression of
noncoding RNAs (Table 7, Fig. 13 and 14). The noncoding small nucleolar RNA Snhg1
was highly expressed and significantly upregulated (Fig 16). Snhg1, also known as the
host gene for U22, is expressed from an intron and is required for processing of 18S
ribosomal RNA (Tycowski 1994). This is consistent with the increase in the expression
of genes involved in ribosome biogenesis and translation in polyoma infected cells.
Another noncoding RNA, Metastasis Associated Lung Adenocarcinma Transcript 1
(MALAT1), was significantly downregulated in infected cells (Fig. 16). Though the
precise function of MALAT1 is still unclear, it has been shown to be involved in a
variety of metastatic cancers (Ji 2003). Its downregulation is consistent with the
downregulation of other genes involved in cell motility in polyoma-infected cells.
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Table 7. Significant changes in noncoding RNAs.

List of noncoding RNAs by name, feature type, and fold change log2 ratio that change
more than 1.5 fold between Mock and PyV infected samples by 36 hours after infection.
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Upregulated
Noncoding RNA
1600020E01Rik
2410006H16Rik
3300005D01Rik
Gm11974
Gm12603
Rmrp
Rpph1
Rprl3
Scarna13
Snhg1
Terc

Feature Type
lincRNA
gene
Unclassified ncRNA
gene
lincRNA
gene
Unclassified ncRNA
gene
lincRNA
gene
RNase MRP RNA
gene
RNase P RNA
gene
RNase P RNA
gene
snoRNA
gene
Unclassified ncRNA
gene
Telomerase RNA
gene

Fold Change Log2
Ratio
1.406401543
1.091248082
1.682985052
1.685511363
2.060374312
1.78468046
2.765659453
2.656127479
1.048926376
1.389978478
1.669975844

Downregulated
Noncoding RNA
2900097C17Rik
Gm13375
Malat1

Unclassified ncRNA
gene
Unclassified ncRNA
gene
lincRNA
gene
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-0.81491907
-1.242099564
-1.412442083

	
  
Figure 16. Example of host noncoding transcripts significantly upregulated or
downregulated in infected samples compared to mock infection.

Noncoding RNA reads from the time course were aligned to the host genome. (Left)
Expression of Snhg2 increases compared to mock infection. (Right) Malat1 decreases
compared to mock infection.
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Taken together, these observations illustrate a change in priority of infected cells
from cell-to-cell interaction, movement, and signal transduction to growth, metabolism,
and DNA synthesis.
Do differentially expressed genes share common patterns of regulation that may
help to explain their response to viral infection? In order to determine common
transcription factor binding sites upstream of differentially expressed genes we used the
Transfind tool (http://transfind.sys-bio.net/) to determine common transcription factor
binding sites among the differentially expressed genes (Kielbasa 2010). Using a
threshold of binding motifs common to the upstream regions of <1000 genes (out of
33,837 genes in the mouse database) and a false discovery rate <0.02, we found a number
of common transcription factor binding sites (Table 8 and 9). As expected the promoters
of upregulated genes were the most enriched for binding sites of the transcription factor
E2F, which is a major cell cycle regulator that is released and activated by the binding of
Large T antigen to pRB (Bracken 2004). Binding sites for members of the CREB-ATF
family of transcription factors were also enriched in the upregulated gene set. This is
consistent with CREB Binding Protein (CBP) and EP300 being targets for large T
antigen, resulting in CRE containing promoters being activated (Goodman 2000). The
nuclear factor kappa B (NFkB), which has been previously shown to be involved in
inflammation, transformation, proliferation, angiogenesis, and metastasis shows binding
sites upstream of the upregulated genes (Aggarwal 2004). Interestingly, STAT1, which
is involved in signal transduction of the interferon pathway, appears to have a common
binding site among a number of the upregulated genes. While the interferon pathway
does not appear to be active (pathway genes were not noted to be strongly up or down
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Table 8. Transfind transcription factor prediction for 36 hour upregulated.

The web based application Transfind was used to predict common transcription factor
binding sites among the lists of upregulated and downregulated host genes. Predictions
of mouse transcription factor binding sites were made with promoter sets of 1000nt from
800nt upstream to 200nt downstream and compared with 1000 genes with the highest
predicted factor affinities among 33,837 total mouse genes. Possible factors were
represented by the TRANSFAC matrix.

103	
  

	
  

Factor
E2F
NF-Y
HIF1
GABP
CREB
ATF
STAT1
CREB
CREBP1
ATF4
AHR
NFkB
YY1
ATF2
CJUN
C-REL
IRF1
ATF3

45
31
30
29

# of
genes
331
345
346
347

Back
ground
+
955
969
970
971

Back
ground
32882
32868
32867
32866

5.46E-04

29

347

971

32866

4.34E-04
4.34E-04
8.25E-04
8.25E-04
8.25E-04
1.07E-02
1.07E-02

4.34E-03
4.34E-03
1.16E-02
1.16E-02
1.16E-02
1.71E-01
1.71E-01

27
27
26
26
26
23
23

349
349
350
350
350
353
353

973
973
974
974
974
977
977

32864
32864
32863
32863
32863
32860
32860

1.78E-03

1.93E-02

3.86E-01

22

354

978

32859

1.78E-03
1.78E-03
1.78E-03

1.93E-02
1.93E-02
1.93E-02

3.86E-01
3.86E-01
3.86E-01

22
22
22

354
354
354

978
978
978

32859
32859
32859

FDR

FP

# of
genes +

<1.00E-07
2.74E-07
8.45E-07
2.52E-06

3.00E-09
1.49E-05
3.06E-05
6.83E-05

9.00E-09
5.94E-05
1.83E-04
5.46E-04

2.52E-06

6.83E-05

2.00E-05
2.00E-05
5.32E-05
5.32E-05
5.32E-05
7.88E-04
7.88E-04

p-value
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Table 9. Transfind transcription factor prediction for 36 hour downregulated.

The web based application Transfind was used to predict common transcription factor
binding sites among the lists of upregulated and downregulated host genes. Predictions
of mouse transcription factor binding sites were made with promoter sets of 1000nt from
800nt upstream to 200nt downstream and compared with 1000 genes with the highest
predicted factor affinities among 33,837 total mouse genes. Possible factors were
represented by the TRANSFAC matrix.
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Factor

p-value

FDR

FP

# of
genes +

SP1
WT1
AP2
TFIII
MAZ
HIC1
KROX
AHRHIF
MZF1
MAZR
HES1
SPZ1
EGR1
MTF1
EGR2
ZIC1
ZIC2
AHR
USF
CACCCBF
HIF1
SMAD4
PAX3
NRF1
AP2a
USF

<1E-09
<1E-09
<1E-09
<1E-09
<1E-09
<1E-09
<1E-09
6.00E-09
3.40E-08
2.22E-06
2.22E-06
4.82E-06
1.02E-05
1.02E-05
2.13E-05
2.13E-05
4.32E-05
8.60E-05
8.60E-05
1.67E-04
3.18E-04
3.18E-04
1.07E-03
1.07E-03
1.07E-03
1.90E-03

3.00E-09
3.00E-09
3.00E-09
3.00E-09
3.00E-09
3.00E-09
3.00E-09
1.10E-07
6.15E-07
3.44E-05
3.44E-05
6.97E-05
1.31E-04
1.31E-04
2.43E-04
2.43E-04
4.69E-04
8.48E-04
8.48E-04
1.58E-03
2.76E-03
2.76E-03
8.31E-03
8.31E-03
8.31E-03
1.42E-02

2.60E-08
2.60E-08
9.00E-09
2.60E-08
2.60E-08
2.60E-08
9.00E-09
1.21E-06
7.39E-06
4.82E-04
4.82E-04
1.05E-03
2.22E-03
2.22E-03
4.61E-03
4.61E-03
9.38E-03
1.87E-02
1.87E-02
3.63E-02
6.90E-02
6.90E-02
2.33E-01
2.33E-01
2.33E-01
4.12E-01

85
82
81
70
69
66
64
58
56
51
51
50
49
49
48
48
47
46
46
45
44
44
42
42
42
41
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# of
genes
781
784
785
796
797
800
802
808
810
815
815
816
817
817
818
818
819
820
820
821
822
822
824
824
824
825

Back
ground
+
915
918
919
930
931
934
936
942
944
949
949
950
951
951
952
952
953
954
954
955
956
956
958
958
958
959

Back
ground
32432
32429
32428
32417
32416
32413
32411
32405
32403
32398
32398
32397
32396
32396
32395
32395
32394
32393
32393
32392
32391
32391
32389
32389
32389
32388

	
  
regulated during infection), the fact that many upregulated genes share the potential to be
affected by it is of interest.
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IV. DISCUSSION

We have presented here a global view of polyomavirus infection with respect to
both the virus and the host transcriptomes. The data and analyses have allowed us to
generate a detailed picture of how viral gene expression changes throughout the life cycle
as well as to learn how infection impacts host cell gene expression. We analyzed RNA
from a number of individual time points, from relatively early in infection (12 hours post
infection) to late times (36 hours post infection) but before extensive cytopathic effects
were noted. Although there were several surprises, the expression and processing of viral
transcripts was generally consistent with previous literature. At early times in infection,
early-strand transcripts dominated over late-strand transcripts. This early pattern is even
more dramatic when DNA replication is blocked with aphidicolin and the infection
allowed to proceed for 48 hours. At early times, most of these transcripts appear to
initiate at a defined site and terminate just downstream of the annotated early
polyadenylation signal. These are spliced to produce mRNAs for the three viral early
proteins, large, middle and small T antigens. However, by 18 hours, after large T antigen
has promoted the onset of viral DNA replication, the pattern of expression reveals a
striking shift toward the late phase, where late-strand RNAs greatly dominate over earlystrand RNAs. This early-to-late switch is characterized by several distinct and important
changes in the pattern of alignments in our data. First, as late messages accumulate
rapidly and genomes replicate, we noted an unexpected shift in the position of the 5’-ends
of early-strand transcripts. At late times, early-strand RNAs appear to initiate over a
broad region upstream of the early TATA box, and throughout the origin of replication.
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We do not yet know why this is the case or how it is regulated, but these findings are
consistent with an earlier report in which the 5’-ends were mapped using nuclease S1
protection (Kamen 1982). Interestingly, this switch depends on viral DNA replication,
since after blocking it with aphidicolin, these upstream 5’-ends were not seen, even after
48 hours.
Another clear change in early-strand expression, and also dependent on DNA
replication, was the appearance and accumulation of reads mapping to a region several
hundred nucleotides downstream of the polyadenylation site. We do not know the
genesis of these reads, and they do not appear to be the result of RNA splicing or a
discrete RNA processing event. Further studies are needed to determine whether these
represent discrete RNA species or regions of early-strand transcripts that have extended
past the polyadenylation site.
Late-strand transcription and processing also changes during infection. While
accumulating to only low levels before viral replication, or in its absence, these RNAs
accumulate rapidly afterwards, and by late times represent the great majority of viral
RNAs in the cell. Their processing may also change with time, although we did not note
any discernible change in transcription start sites. As others have reported before, late
transcription can proceed many times around the circular viral genome, leading to a
heterogeneous collection of giant transcripts that can serve as precursors to mature late
mRNAs (Acheson 1971, Aloni 1973, Heiser 1982, Adami 1989, Gu 2009). Processing
involves not only alternative splicing to generate messages for VP1, VP2 and VP3, but
also the splicing of noncoding late leader exons at their 5’-ends. The number of tandem
leader units appearing on late mRNAs reflects the number of transits around the genome
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made by RNA polymerase II before transcription termination and polyadenylation. We
noted a striking accumulation of leader-leader splicing events at late times in infection.
These were only seen at late times, and after DNA replication.
Late leader splicing requires inefficient late-strand transcription termination and
polyadenylation. We have reported previously that this is the result of particular viral
genomic features in the early/late polyadenylation region (Gu 2009). These sites overlap
on the genome and this affords viral transcripts the opportunity to anneal with one
another, leading to dsRNA in the nucleus. dsRNA formation could alter normal 3’-end
processing by interfering with the polyadenylation machinery. Also, dsRNA formation
could lead to promiscuous editing by ADAR1, leading to RNAs that cannot be
recognized by the processing machinery. We have previously found that viruses that
cannot generate early-strand and late-strand transcripts that overlap are incapable of the
early-late switch (Gu 2009). The consequences of such dsRNA formation are of
profound importance for the virus. Inefficient late-strand termination leads to the
multigenomic transcripts that serve as precursors to late mRNAs (Acheson 1971, Aloni
1973, Heiser 1982, Adami 1989). Early-strand termination is likely also to become less
efficient, but in this case the multigenomic transcripts are not used for mRNA production,
but are rather likely degraded in the nucleus owing to unproductive splicing. Our data
support these concepts. While our transcriptomic data reveal mostly the accumulated
mature mRNAs at late times, close inspection reveals roughly equal levels of poly(A) site
readthrough transcripts on each strand. These would be expected to be capable of
dsRNA formation, leading to ADAR editing. Indeed, A-to-G mismatches consistent with
A-to-I editing were observed to only occur at late times in cells untreated with replication
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inhibitor, with robust editing observed in the overlapping polyadenylation sites. The
hyperediting pipeline we employed allowed us for the first time to capture polyoma reads
that would otherwise be too heavily altered to be identified. The increase in edited
clusters aligning along the entire length of the reference genome was predicted but, to our
knowledge, has never been directly observed until now. Taken together, these
observations confirm previous models of the early-late switch that describe a loss of
polyadenylation efficiency concomitant with an increase in editing of the polyadenylation
sites resulting in giant multigenomic RNAs, which can be spliced to generate multiple
late leader exons on late mRNAs.
Alignment of reads from the time course infection to the host genome showed the
greatest change between mock and infected samples by 36 hours, allowing us to observe
the accumulated effects of the virus on the host transcriptome. We suspect later time
points might yield more genes changing more than 2 fold up or down but time points
closer to 72 hours would be entering the lysis phase of the viral life cycle and any
observed changes would likely be difficult to separate from those associated with host
cell death. At 36 hours post infection, we found 359 genes significantly upregulated and
857 genes significantly downregulated. Many of the genes upregulated were involved in
predicted processes such as metabolism, ribosome synthesis, mitochondrial proteins, and
cell cycle progression. This is consistent with the action of viral T antigens in stimulating
the proliferation of host cells. Many downregulated genes were also largely unsurprising
with those involved in cell motility, extracellular matrix, and cell signaling processes
prominent on the list. Finally, we noted the upregulation or downregulation of several
abundant long noncoding RNAs. There are several lncRNAs of particular interest. One
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is Malat1 (downregulated), which has been associated with metastasis and which may
play a role in RNA processing (Ji 2003). Another is Terc (upregulated), which is
involved in telomere maintenance and cellular lifespan (Artandi 2010). Finally, several
lncRNAs associated with RNAse P enzymes are also strongly upregulated. We do not
yet know the significance of this, but such molecules have been implicated in tRNA and
ribosomal biogenesis, which is consistent with the observed increase in host translation in
infected samples (Lai 2010).
Here we have presented for the first time a global analysis of both viral and host
transcriptional changes from a mouse polyomavirus infection. The viral transcriptome
analysis revealed insights into changes in RNA expression, especially with respect to the
early strand at late times and confirmed a number of previous observations of the
polyoma lifecycle. This is the most direct evidence of widespread hyper-editing of viral
RNA predicted from a model of extensive early and late strand transcription. The
observations of changes in host transcription also confirm a number of predictions
including the increase in genes involved in cell growth, metabolism, and translation.
Future investigation into more precise aspects of the lifecycle including later time points,
nuclear and cytoplasmic fractionation, and PolyA plus and minus samples may yield
further insight into the viral-host interactions.

V. FUTURE DIRECTIONS
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The observations made by this investigation into the polyomavirus infection offer
some of the most comprehensive insight into the changes in both viral and host
transcription. Despite this, a number of questions still remain. What kind of differences
would be observed in nuclear vs cytoplasmic or polyA+ vs polyA- RNA from mock and
infected samples? We might expect to see more defined viral alignments consistent with
mature mRNA in the cytoplasmic fractions and more readthrough from the giant
transcripts in the nuclear fractions at late times. PolyA- selection might also reveal more
noncoding RNAs in the host. What changes in splicing or editing clusters of host genes
are observed between mock and infected samples at early and late times? Perhaps some
transcripts that are regulated by processes dependent on the presence of double stranded
RNA are affected by virus infection. Do the changes in transcription also produce the
same changes in translation? We know of a number of post-translational modifications
that are associated with the signaling pathways activated by viral tumor antigens but a
more global profile of those changes has not yet been pursued. What is the precise nature
of the shift in the 5’ ends of early transcripts at late times? Is it the result of more subtle
changes in viral chromatin states beyond initial hyperacetylation? How does DNA
replication and the early late switch affect transcription factor binding? Does the process
of DNA replication allow transcription factors to better access the late transcription start
site contained within the A enhancer? What would happen if the A enhancer was moved
to the early side of the origin or the Large T binding sites moved to the late? Is editing a
byproduct of the fact that viral DNA forms double stranded RNA or is it necessary for
loss of polyadenylation and subsequent production of giant transcripts? These are just a
few of the questions that remain to be investigated.

113	
  

	
  

114	
  

	
  
VI. REFERENCES
Acheson NH, Buetti E, Scherrer K, Weil R: Transcription of the Polyoma Virus Genome:
Synthesis and Cleavage of Giant Late Polyoma–Specific RNA. Proc Natl Acad Sci USA
1971, 68(9): 2231-2235
Acheson NH: Efficiency of Processing of Viral RNA During the Early and Late Phases
of Productive Infection by Polyoma Virus. J Virol 1981, 37(2): 628-635
Acheson NH: Kinetics and Efficiency of Polyadenylation of Late Polyomavirus Nuclear
RNA: Generation of Oligomeric Polyadenylated RNAs and Their Processing into
mRNA. Mol Cell Biol 1984, 4(4): 722-729
Acheson NH: Polyoma virus giant RNAs contain tandem repeats of the nucleotide
sequence of the entire viral genome. Proc Natl Acad Sci USA 1978, 75(10): 4754-4758
Achesone NH, Mieville F: Extent of Transcription of the E Strand of Polyoma Virus
DNA During the Early Phase of Productive Infection. J Virol 1978, 28(3): 885-894
Adami GR Carmichael GG: Polyomavirus Late Leader Region Serves an Essential
Spacer Function Necessary for Viability and Late Gene Expression. J Virol 1986, 58(2):
417-425
Adami GR, Marlor CW, Barrett NL, Carmichael GG: Leader-to-Leader Splicing Is
Required for Efficient Production and Accumulation of Polyomavirus Late mRNAs. J
Virol 1989, 63(1): 85-93
Aggarwal B: Nuclear factor-kB: The enemy within. Cancer Cell 2004, 6: 203-208
Aloni Y, Locker H: Symmetrical in Vivo Transcription of Polyoma DNA and the
Separation of Self-Complementary Viral and Cell RNA. Virology 1973, 54: 495-505
An K, Fattaey HK, Paulsen AQ, Consigli RA: Murine polyomavirus infection of 3T6
mouse cells shows evidence of predominant necrosis as well as limited apoptosis. Virus
Res 2000, 67: 81-90
Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R: A family of transcriptional
adaptor proteins targeted by the E1A oncoprotein. Nature 1995, 374: 81-84
Arany Z, Sellers WR, Livingston DM, Eckner R: E1A-Associated p300 and CREBAssociated CBP Belong to a Conserved Family of Coactivators. Cell 1994, 77: 799-800
Arrand JR, Soeda E, Walsh JE, Smolar N, Griffin BE: Polyoma virus DNA: Sequence
from the late region that specifies the leader sequence for late mRNA and codes for VP2,
VP3, and the N-teminus of VP1. J Virol 1980, 33(2): 606-618

115	
  

	
  

Artandi SE, DePinho R: Telomeres and telomerase in cancer. Carcinogenesis 2010,
31(1): 9-18
Asselin C, Bastin M: Sequences from Polyomavirus and Simian Virus 40 Large T Genes
Capable of Immortalizing Primary Rat Embryo Fibroblasts. J Virol 1985, 56(3): 958-968
Ballmer-Hofer K, Benjamin TL: Phosphorylation of polyoma middle T antigen and
cellular proteins in purified plasma membranes of polyoma virus-infected cells. EMBO J
1985, 4(9): 2321-2327
Basilico C, Di Mayorca G: Radiation Target Size of the Lytic and the Transforming
Ability of Polyoma Virus. Proc Natl Acad Sci USA 1965 54(1): 125-127
Bass BL: RNA Editing by Adenosine Deaminases That Act on RNA. Annu Rev Biochem
2002, 71: 817-846
Beard P, Acheson NH, Maxwell IH: Strand-Specific Transcription of Polyoma Virus
DNA Early in Productive Infection and in Transformed Cells. J Virol 1976, 17(1): 20-26
Benjamin TL: Relative Target Sizes for the Inactivation of the Transforming and
Reproductive Abilities of Polyoma Virus. Proc Natl Acad Sci USA 1965, 54: 121-124
Benjamin TL: Virus-specific RNA in cells productively infected or transformed by
polyoma virus. J Mol Biol 1966, 16(2): 359-373
Benjamin TL: Host Range Mutants of Polyoma Virus. Proc Natl Acad Sci USA 1970,
67(1): 394-399
Benjamin TL, Burger MM: Absence of a Cell Membrane Alteration Function in Nontransforming Mutants of Polyoma Virus. Proc Natl Acad Sci USA 1970, 67(2): 929-934
Bickerboller M, Tagscherer KE, Kloor M, Jansen L, Chang-Claude J, Brenner H, et al:
Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and
its association with survival. Oncogene 2015, 34(9): 1150-1159
Birg F, Favaloro J, Kamen R: Analysis of polyoma virus nuclear RNA by mini-blot
hybridization. Proc Natl Acad Sci USA 1977, 74(8): 3138-3142
Bolen JB, Thiele CJ, Israel MA, Yonemoto W, Lipsich LA, Brugge JS: Enhancement of
Cellular src Gene Product Associated Tyrosyl Kinase Activity following Polyoma Virus
Infection and Transformation. Cell 1984, 38: 767-777
Bolwig GM, Hearing P: Interaction of Nuclear Factor EF-1A with the Polyomavirus
Enhancer Region. J Virol 1991, 65: 1884-1892

116	
  

	
  
Bracken AP, Ciro M, Cocito A, Helin K: E2F target genes: unraveling the biology.
TRENDS Biochem Sci 2004, 29(8): 409-417
Brooks G, Brooks SF, Goss MW: MARCKS functions as a novel growth suppressor in
cells of melanocyte origin. Carcinogenesis 1996, 17(4): 683-689
Cai X, Chang D, Rottinghaus S, Consigli RA: Expression and Purification of
Recombinant Polyomavirus VP2 Protein and Its Interactions with Polyomavirus Proteins.
J Virol 1994, 68(11): 7609-7613
Campbell KS, Auger KR, Hemmings BA, Roberts TM, Pallas DC: Identification of
Regions in Polyomavirus Middle T and Small t Antigens Important for Association with
Protein Phosphatase 2A. J Virol 1995, 69(6): 3721-3728
Campbell KS, Ogris E, Burke B, Su W, Auger KR, Druker BJ, Schaffhausen BS, Roberts
TM, Pallas DC: Polyoma middle tumor antigen interacts with SHC protein via the NPTY
(Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc Natl Acad Sci USA 1994, 91:
6344-6348
Carbone M, Reale A, Di Sauro A, Sthandier O, Garcia M, Maione R, Caiafa P, Amati P:
PARP-1 Interaction with VP1 Capsid Protein Regulates Polyomavirus Early Gene
Expression. J Mol Biol 2006, 363: 773-785
Carmichael GG, Schaffhausen BS, Dorsky DI, Oliver DB, Benjamin TL: Carboxy
terminus of polyoma middle-sized tumor antigen is required for attachment to
membranes, associated protein kinase activities, and cell transformation. Proc Natl Acad
Sci USA 1982, 79:3579-3583
Carmichael G, Schaffhausen BS, Mandel G, Liang TJ, Benjamin TL: Transformation by
polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at
residue 315 of middle-sized tumor antigen. Proc Natl Acad Sci USA 1984, 81: 679-683
Caruso M, Iacobini C, Passananti, Felsani A, Amati P: Protein recognition sites in
polyomavirus enhancer: formation of a novel site for NF-1 factor in an enhancer mutant
and characterization of a site in the enhancer D domain. EMBO J 1990, 9: 947-955
Chang D, Cai X, Consigli RA: Characterization of the DNA Binding Properties of
Polyomavirus Capsid Proteins. J Virol 1993, 67(10): 6327-6331
Cheetham M, Brion J, Anderton B: Human homologues of the bacterial heat-shock
protein DnaJ are preferentially expressed in neurons. Biochem J 1992, 284: 469-476
Chen L, Fluck MM: Role of Middle T-Small T in the Lytic Cycle of Polyomavirus:
Control of the Early-to-Late Transcriptional Switch and Viral DNA Replication. J Virol
2001, 75: 8380-8389

117	
  

	
  
Chen L, Wang X, Fluck MM: Independent Contributions of Polyomavirus Middle T and
Small T to the Regulation of Early and Late Gene Expression and DNA Replication. J
Virol 2006, 80: 7295-7307
Chen MC, Redenius D, Osati-Ashtiani F, Fluck MM: Enhancer-Mediated Role for
Middle T/Small T in DNA replication. J Virol 1995, 69: 326-333
Chen MH, Benjamin TL: Roles of N-Glycans with alpha 2,6, as well as alpha2,3 Linked
Sialic Acid in Infeciton by Polyoma Virus. Virology 1997, 233: 440-442
Chen MCY, Chang KSS, Salzman NP: Studies of Polyoma Virus DNA: Cleavage Map of
the Polyoma Virus Genome. J Virol 1975, 15(1): 191-198
Chiu R, Angel P, Karin M: Jun-B Differs in Its Biological Properties from, and Is a
Negative Regulator of, c-Jun. Cell 1989, 59:979-986
Cho S, Tian Y, Benjamin TL: Binding of p300/CBP Co-activators by Polyoma Large T
Antigen. J Biol Chem 2001, 276(36): 33533-33539
Chromy LR, Oltman A, Estes PA, Garcea RL: Chaperone-Mediated In Vitro
Disassembly of Polyoma- and Papillomaviruses. J Virol 2006, 80(10): 5086-8091
Cogen B, Eckhart W: BALB/3T3 Cells Infected by the ts3 Mutant of Polyoma Virus Fail
to Accumulate Virus-Specific Early RNA at the Nonpermissive Temperature. J Virol
1977, 24(2): 701-703
Condit RC, Cowie A, Kamen R, Birg F: Polyoma Virus Transcription in Vitro. J Mol
Biol 1977, 115: 215-235
Courtneidge SA, Heber A: An 81 kd Protein Complexed with Middle T Antigen and
pp60c-src: A Possible Phosphatidylinositol Kinase. Cell 1987, 50: 1031-1037
Courtneidge SA, Smith AE: Polyoma virus transforming protein associates with the
product of the c-src cellular gene. Nature 1983, 303: 435-439
Cowie A, de Villiers J, Kamen R: Immortalization of Rat Embryo Fibroblasts by Mutant
Polyomavirus Large T Antigens Deficient in DNA Binding. Mol Cell Biol 1986, 6(12):
4344-4352
Cowie A, Jat P, Kamen R: Determination of Sequences at the Capped 5’ Ends of
Polyoma Virus Early Region Transcripts Synthesized in vivo and in vitro Demonstrates
an Unusual Microheterogeneity. J Mol Biol 1982, 159: 225-255
Cowie A, Kamen R: Multiple Binding Sites for Polyomavirus Large T Antigen within
Regulatory Sequences of Polyomavirus DNA. J Virol 1984, 52(3): 750-760

118	
  

	
  
Cowie A, Tyndall C, Kamen R: Sequences at the capped 5’-ends of polyoma virus late
region mRNAs: an example of extreme terminal heterogeneity. Nucleic Acids Res 1981,
9(23): 6305-6322
Crawford LV: The Adsorption of Polyoma Virus. Virology 1962, 18(2): 177-181 (A)
Crawford LV, Crawford EM, Watson DH: The Physical Characteristics of Polyoma
Virus I. Two Types of Particle. Virology 1962, 18(2): 170-176 (B)
Crawford LV, Dulbecco R, Fried M, Montagnier L, Stoker M: Cell Transformation by
Different Forms of Polyoma Virus DNA. Proc Natl Acad Sci USA 1964, 52: 148-152
Crawford LV, Syrett C, Wilde A: The Replication of Polyoma DNA. J gen Virol 1973,
21: 515-521
Crawford LV, Robbins AK, Nicklin PM: Location of the Origin and Terminus of
Replication in Polyoma Virus DNA. J gen Virol 1974, 25: 133-142
Cremisi C, Pignatti PF, Croissant O, Yaniv M: Chromatin-Like Structures in Polyoma
Virus and Simian Virus 40 Lytic Cycle. J Virol 1976, 17(1): 204-211
Cripe TP, Delos SE, Estes PA, Garcea RL: In Vivo and In Vitro Association of Hsc70
with Polyomavirus Capsid Proteins. J Virol 1995, 69(12): 7807-7813
Dahl J, Chen I, George M, Benjamin TL: Polyomavirus Small T Antigen Controls Viral
Chromatin Modifications through effects on Kinetics of Virus Growth and Cell Cycle
Progression. J Virol 2007, 81(18): 10064-10071
Dandolo L, Blangy D, Kamen R: Regulation of Polyoma Virus Transcription in Murine
Embryonal Carcinoma Cells. J Virol 1983, 47(1): 55-64
Deininger P, Esty A, LaPorte P, Friedmann T: Nucleotide Sequence and Genetic
Organization of the Polyoma Late Region: Features Common to the Polyoma Early
Region and SV40. Cell 1979, 18: 771-779
Deininger P, Esty A, LaPorte P, Hsu H, Friedmann T: The nucleotide sequence and
restriction enzyme sites of the polyoma genome. Nucleic Acids Res 1980, 8(4): 855-860
Delos SE, Montross L, Moreland RB, Garcea RL: Expression of the Polyomavirus VP2
and VP3 Proteins in Insect Cells: Coexpression with the Major Capsid Protein VP1
Alters VP2/VP3 Subcellular localization. Virology 1993, 194: 393-398
Desjardins P, Pilon AA, Hassell JA, Mes-Masson A: Polyomavirus large T-antigen binds
the “pRb related” protein p130 through sequences in conserved region 2. Virus Res 1997,
47: 85-90

119	
  

	
  
de Villiers J, Olson L, Tyndall C, Schaffner W: Transcriptional ‘enhancers’ from SV40
and polyoma virus show a cell type preference. Nucleic Acids Res 1982, 10(24): 79657976
de Villiers J, Schaffner W: A small segment of polyoma virus DNA enhances the
expression of a cloned beta-globin gene over a distance of 1400 base pairs. Nucleic Acids
Res 1981, 9(23): 6251-6264
de Villiers J, Schaffner W, Tyndall C, Lupton S, Kamen R: Polyoma virus DNA
replication requires an enhancer. Nature 312: 242-246
Dilworth SM, Brewster CE, Jones MD, Lanfrancone L, Pelicci G, Pelicci PG:
Transformation by polyoma virus middle T-antigen involves the binding and tyrosine
phosphorylation of Shc. Nature 1994, 367: 87-90
Dilworth S, Cowie A, Kamen R, Griffin B: DNA binding activity of polyoma virus large
tumor antigen. Proc Natl Acad Sci 1984, 81: 1941-1945
DiMayorca GA, Callender J, Marin G, Giordano R: Temperature-Sensitive Mutants of
Polyoma Virus. Virology 1969, 38: 126-133
DiMayorca GA, Eddy BE, Stewart SE, Hunter WS, Friend C, Bendich A: Isolation of
Infectious Deoxyribonucleic Acid from SE Polyoma-Infected Tissue Cultures. Proc Natl
Acad Sci USA 1959, 45: 1805-1808
Doherty J, Freund R: Polyoma large T antigen overcomes p53 dependent growth arrest.
Oncogene 1997, 14: 1923-1931
Dulbecco R, Eckhart W: Temperature-Dependent Properties of Cells Transformed by a
Thermosensitive Mutant of Polyoma Virus. Proc Natl Acad Sci USA 1970, 67(4): 17751781
Dyson N, Bernards R, Friend S, Gooding L, Hassel J, Major E, Pipas J, Vandyke T,
Harlow E: Large T Antigens of Many Polyomaviruses Are Able to Form Complexes with
the Retinoblastoma Protein. J Virol 1990, 64(3): 1353-1356
Eckhart W: Complementation and transformation by temperature-sensitive mutants of
polyoma virus. Virology 1969, 38: 120-125
Eckhart W: Complementation between Temperature-sensitive (ts) and Host Range
Nontransforming (hr-t) Mutants of Polyoma Virus. Virology 1977, 77: 589-597
Eckhart W: Induced cellular DNA synthesis by ‘early’ and ‘late’ temperature-sensitive
mutants of polyoma virus. Proc Roy Soc Lond 1971, 177: 59-63 (A)

120	
  

	
  
Eckhart W, Dulbecco R: Properties of the ts3 Mutant of Polyoma Virus during Lytic
Infection. Virology 1974, 60: 359-369
Eckhart W, Dulbecco R, Burger MM: Temperature-Dependent Surface Changes in Cells
Infected or Transformed by a Thermosensitive Mutant of Polyoma Virus. Proc Natl Acad
Sci USA 1971, 68(2): 283-286 (B)
Eckhart W, Hutchinson M, Hunter T: An Activity Phosphorylating Tyrosine in Polyoma
T Antigen Immunoprecipitates. Cell 1979, 18: 925-933
Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston
DM: Molecular cloning and functional analysis of the adenovirus E1A-associated 300kD
protein (p300) reveals a protein with properties of a transcriptional adaptor. Gene Dev
1994, 8: 869-884
Eckner R, Ludlow JW, Lill NL, Oldread E, Arany Z, Modjtahedi N, DeCaprio JA,
Livingston DM, Morgan JA: Association of p300 and CBP with Simian Virus 40 Large T
Antigen. Mol Cell Biol 1996, 16: 3454-3464
Eddy BE, Rowe WP, Hartley JW, Stewart SE, Huebner RJ: Hemagglutination with the S
E polyoma virus. Virology 1958, 6(1): 290-291
Feunteun J, Sompayrac L, Fluck M, Benjamin TL: Localization of gene functions in
polyoma virus DNA. Proc Natl Acad Sci USA 1976, 73(11): 4169-4173
Finch JT: The Surface Structure of Polyoma Virus. J gen Virol 1974, 24(2): 359-364
Flavell AJ, Cowie A, Legon S, Kamen R: Multiple 5’ Terminal Cap Structures in Late
Polyoma Virus RNA. Cell 1979, 16: 357-371
Flavell AJ, Cowie A, Arrand JR, Kamen R: Localization of Three Major Capped 5’ Ends
of Polyoma Virus Late mRNA’s Within a Single Tetranucleotide Sequence in the Viral
Genome. J Virol 1980, 33(2): 902-908
Flavell AJ, Kamen R: Strand-Specific Transcription of Polyoma Virus DNA Late During
Productive Infection. J Mol Biol 1977, 115: 237-242
Fluck MM, Benjamin TL: Comparisons of Two Early Gene Functions Essential for
Transformation in Polyoma Virus and SV-40. Virology 1979, 96: 205-228
Fluck MM, Staneloni RJ, Benjamin TL: Hr-t and ts-a: Two Early Gene Functions of
Polyoma Virus. Virology 1977, 77: 610-624
Francke B, Eckhart W: Polyoma Gene Function Required for Viral DNA Synthesis.
Virology 1973, 55: 127-135

121	
  

	
  
Frearson PM, Crawford LV: Polyoma Virus Basic Proteins. J gen Virol 1972, 14: 141155
Freund R, Bronson RT, Benjamin TL: Separation of immortalization from tumor
induction with polyoma large T mutants that fail to bind the retinoblastoma gene product.
Oncogene 1992, 7(10): 1979-1987
Fried M: Characterization of a Temperature-Sensitive Mutant of Polyoma Virus.
Virology 1970, 40: 605-617
Fried M: Isolation of temperature-sensitive mutants of polyoma virus. Virology 1965,
25:669-671
Friedmann T, David D: Structural Roles of Polyoma Virus Proteins. J Virol 1972, 10(4):
776-782
Friedmann T, Esty A, LaPorte P, Deininger P: The Nucleotide Sequence and Genome
Organization of the Polyoma Early Region: Extensive Nucleotide and Amino Acid
Homology with SV40. Cell 1979, 17: 715-724
Friedmann T, LaPorte P, Esty A: Nucleotide Sequence Studies of Polyoma DNA. J Biol
Chem 1978, 253(18): 6561-6567
Friedmann T: Structural Proteins of Polyoma Virus: Proteolytic Degradation of Virion
Proteins by Exogenous and by Virion-Associated Proteases. J Virol 1976, 20(4): 520-526
Fujimura FK, Linney E: Polyoma mutants that productively infect F9 embryonal
carcinoma cells do not rescue wild-type polyoma in F9 cells. Proc Natl Acad Sci USA
1982, 79: 1479-1483
Garcea RL, Talmage DA, Harmatz A, Freund R, Benjamin TL: Separation of the Host
Range from the Transformation Functions of the hr-t gene of Polyomavirus. Virology
1989, 168: 312-319
Gibson W, Hunter T, Cogen B, Eckhart W: Altered Virion Proteins of a TemperatureSensitive Mutant of Polyoma Virus, ts59. Virology 1977, 80: 21-41
Gillock ET, Rottinghaus S, Chang D, Cai X, Smiley SA, An K, Consigli RA:
Polyomavirus Major Capsid Protein VP1 Is Capable of Packaging Cellular DNA When
Expressed in the Baculovirus System. J Virol 1997, 71(4): 2857-2865
Gjorup O, Rose P, Holman P, Bockus B, Schaffhausen B: Protein domains connect cell
cycle stimulation directly to initiation of DNA replication. Proc Natl Acad Sci 1994, 91:
12125-12129

122	
  

	
  
Glover H, Brewster CEP, Dilworth SM: Association between src-kinases and the
polyomavirus oncogene middle T-antigen requires PP2A and a specific sequence motif.
Oncogene 1999, 18: 4364-4370
Goldman E, Benjamin TL: Analysis of Host Range of Nontransforming Polyoma Virus
Mutants. Virology 1975, 66: 372-384
Goodman RH, Smolik S: CBP/p300 in cell growth, transformation, and development.
Genes Dev 2000, 14: 1553-1577
Gotoh N, Tojo A, Shibuya M: A novel pathway from phosphorylation of tyrosine
residues 239/240 of Shc, contributing to suppress apoptosis by IL-3. EMBO J 1996,
15(22): 6197-6204
Griffin BE, Fried M, Cowie A: Polyoma DNA: A Physical Map. Proc Natl Acad Sci USA
1974, 71(5): 2077-2081
Griffith GR, Consigli RA: Isolation and Characterzation of Monopinocytic Vesicles
Containing Polyomavirus from the Cytoplasm of Infected Mouse Kidney Cells. J Virol
1984, 50(1): 77-85
Gross L: A filterable agent, recovered from AK leukemic extracts, causing salivary gland
carcinomas in C3H mice. Proc Soc Exp Biol Med 1953, 83: 414-417
Gu R, Zhang Z, DeCerbo JN, Carmichael GG: Gene regulation by sense-antisense
overlap of polyadenylation signals. RNA 2009, 15: 1154-1163
Habel K: Specific Complement-Fixing Antigens in Polyoma Tumors and Transformed
Cells. Virology 1965, 25: 55-61
Habel K, Silverberg RJ: Relationship of Polyoma Virus and Tumor in Vivo. Virology
1960, 12: 463-476
Harvey R, Oostra BA, Belsham GJ, Gillet P, Smith AE: An antibody to a synthetic
peptide recognizes polyomavirus middle-T antigen and reveals multiple in vitro tyrosine
phosphorylation sites. Mol Cel Biol 1984, 4(7): 1334-1342
Hattori J, Carmichael GG, Benjamin TL: DNA Sequence Alterations in Hr-t Deletion
Mutants of Polyoma Virus. Cell 1979, 16: 505-513
Heiser WC, Eckhart W: Polyoma Virus Early and Late mRNAs in Productively Infected
Mouse 3T6 Cells. J Virol 1982, 44(1): 175-188
Herbomel P, Bourachot B, Yaniv M: Two Distinct Enhancers with Different Cell
Specificities Coexist in the Regulatory Region of Polyoma. Cell 1984, 39: 653-662

123	
  

	
  
Herbomel P, Saragosti S, Blangy D, Yaniv M: Fine Structure of the Origin-Proximal
DNAase I-Hypersensitive Region in Wild-type and EC Mutant Polyoma. Cell 1981, 25:
651-658
Hewick RM, Fried M, Waterfield MD: Nonhistone Virion Proteins of Polyoma:
Characterisation of the Particle Proteins by Tryptic Peptide Analysis by Use of IonExchange Columns. Virology 1975, 66(2): 408-419
Holman P, Gjoerup O, Davin T, Schaffhausen B: Characterization of an Immortalizing
N-Terminal Domain of Polyomavirus Large T Antigen, J Virol 1994, 68(2): 668-673
Horak ID, Kawakami T, Gregory F, Robbins KC, Bolen JB: Association of p60fyn with
middle tumor antigen in murine polyomavirus-transformed rat cells. J Virol 1989, 63(5):
2343-2347
Hudson J, Goldstein D, Weil R: A Study on the Transcription of the Polyoma Viral
Genome. Proc Natl Acad Sci USA 1970, 65(1): 226-233
Huerfano S, Zila V, Boura E, Spanielova H, Stokrova J, Forstova J: Minor capsid
proteins of mouse polyomavirus are inducers of apoptosis when produced individually
but are only moderate contributers to cell death during the late phase of viral infection.
FEBS J 2010, 277(5): 1270-1283
Hunter T, Hutchinson MA, Eckhart W: Translation of polyoma virus T antigens in vitro.
Proc Natl Acad Sci USA 1978, 75(12): 5917-5921
Hunter T, Hutchinson MA, Eckhart W: Polyoma middle-sized T antigen can be
phosphorylated on tyrosine at multiple sites in vitro. EMBO J 1984, 3(1): 73-79
Hutchinson M, Hunter T, Eckhart W: Characterization of T Antigens in PolyomaInfected and Transformed Cells. Cell 1978, 15: 65-77
Hyde-DeRuyscher R, Carmichael GG: Polyomavirus early-late switch is not regulated at
the level of transcription initiation and is associated with changes in RNA processing.
Proc Natl Acad Sci USA 1988, 85: 8993-8997
Hyde-DeRuyscher RP, Carmichael GG: Polyomavirus Late Pre-mRNA Processing: DNA
Replication-Associated Changes in Leader Exon Multiplicity Suggest a Role for Leaderto-Leader Splicing in the Early-Late Switch. J Virol 1990, 64(12): 5823-5832
Ito Y: Polyoma Virus-Specific 55K Protein Isolated from Plasma Membrane of
Productively Infected Cells Is Virus-Coded and Important for Cell Transformation.
Virology 1979, 98: 261-266

124	
  

	
  
Ito Y, Brocklehurst JR, Dulbecco R: Virus-specific proteins in the plasma membrane of
cells lytically infected or transformed by polyoma virus. Proc Natl Acad Sci USA 1977,
74(10): 4666-4670
Ito Y, Spurr N, Griffin BE: Middle T Antigen as Primary Inducer of Full Expression of
the Phenotype of Transformation by Polyoma Virus. J Virol 1980, 35(1): 219-232
Jat P, Novak U, Cowie A, Tyndall C, Kamen R: DNA Sequences Required for Specific
and Efficient Initiation of Transcription at the Polyoma Virus Early Promoter. Mol Cell
Biol 1982, 2(7): 737-751 (B)
Jat P, Roberts JW, Cowie A, Kamen R: Comparison of the polyoma virus early and late
promoters by transcription in vitro. Nucleic Acids Res 1982, 10(3): 871-887 (A)
Ji P, Diedrichs S, Wang W, Boing S, Metzger R, Schneider PM, et al: MALAT-1, a novel
noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage nonsmall cell lung cancer. Oncogene 2003, 22(39): 8031-8041
Joseph CK, Qureshi SA, Wallace DJ, Foster DA: MARCKS protein is transcriptionally
down-regulated in v-Src-transformed BALB/c 3T3 cells. J Bio Chem 1992, 267(2): 13271330
Kamen R, Jat P, Treisman R, Favaloro J: 5’ Termini of Polyoma Virus Early Region
Transcripts Synthesized in vivo by Wild-type Virus and Viable Deletion Mutants. J Mol
Biol 1982, 159: 189-224
Kamen R, Lindstrom DM, Shure H, Old RW: Virus-specific RNA in cells productively
infected or transformed by polyoma virus. Cold Spring Harbor Symp Quant Biol 1975,
39: 187
Kamen R, Shure H: Topography of Polyoma Virus Messenger RNA Molecules. Cell
1976, 7: 361-371
Kamen RI, Wheeler T, Smith AE: Polyoma Virus High Molecular Weight Nuclear RNA
Codes for Capsid Protein VP2 in Vitro. Virology 1978, 89: 461-474
Kamen R, Favaloro J, Parker J: Topography of the Three Late mRNA’s of Polyoma
Virus Which Encode the Virion Proteins. J Virol 1980, 33(2): 637-651
Kaplan DR, Whitman M, Schaffhausen B, Pallas DC, White M, Cantley L, Roberts TM:
Common Elements in Growth Factor Stimulation and Oncogenic Transformation: 85 kd
Phosphoprotein and Phosphatidylinositol Kinase Activity. Cell 1987, 50: 1021-1029
Kaplan DR, Whitman M, Schaffhausen B, Raptis L, Garcea RL, Pallas D, Roberts TM,
Cantley L: Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc
Natl Acad Sci USA 1986, 83: 3624-3628

125	
  

	
  

Katinka M, Vasseur M, Montreau N, Yaniv M, Blangy D: Polyoma DNA sequences
involved in control of viral gene expression in murine embryonal carcinoma cells. Nature
1981, 290: 720-722
Katinka M, Yaniv M: Expression of Polyoma Early Functions in Mouse Embryonal
Carcinoma Cells Depends on Sequence Rearrangements in the Beginning of the Late
Region. Cell 1980, 20: 393-399
Katinka M, Yaniv M: DNA Replication Origin of Polyoma Virus: Early Proximal
Boundary. J Virol 1983, 47(1): 244-248
Kelley W, Landry SJ: Chaperone power in a virus? Trends Biochem Sci 1994, 19: 227278
Kern FG, Pellegrini Cowie A, Basilico C: Regulation of Polyomavirus Late Promoter
Activity by Viral Early Proteins. J Virol 1986, 60(1): 275-285
Kielbasa SM, Klein H, Roider HG, Vingron M, Bluthgen N: Transfind-predicting
transcriptional regulators for gene sets. Nucleis Acids Res 2010, 38: W275-W280
Klug A: Structure of Viruses of the Pappiloma-Polyoma Type II. Comments on Other
Work. J Mol Biol 1965, 11(2): 424-431
Kornbluth S, Sudol M, Hanafusa H: Association of the polyomavirus middle-T antigen
with c-yes protein. Nature 1987, 325: 171-173
Kumar M, Carmichael GG: Nuclear antisense RNA induces extensive adenosine
modifications and nuclear retention of target transcripts. Proc Natl Acad Sci USA 1997,
94: 3542-3547
Lai LB, Vioque A, Kirsebom LA, Gopalan V: Unexpected diversity of RNase P, and
ancient tRNA processing enzyme: challenges and prospects. FEBS Lett 2010, 584(2):
287-296
Lane DP, Crawford LV: T-antigen is bound to a host protein in SV40-transformed cells.
Nature 1979, 278: 261-263
Larose A, Dyson N, Sullivan M, Harlow E, Bastin M. Polyomavirus Large T Mutants
Affected in Retinoblastoma Protein Binding Are Defective in Immortalization. J Virol
1991, 65(5): 2308-2313
Laterjet R, Cramer R, Montagnier L: Inactivation, by UV-, X-, and gamma-radiations, of
the infecting and transforming capacities of polyoma virus. Virology 1967, 33(1): 104111

126	
  

	
  
Laux T, Fukami K, Thelen M, Golub T, Frey D, Caroni P: GAP43, MARCKS, and
CAP23 modulate PI(4,5)P(2) at plasmalemmel rafts, and regulate cell cortex actin
dynamics through a common mechanism. J Cell Biol 2000, 149(7):1455-1472
Legon S: The Binding of Ribosomes to Polyoma Virus RNA: Possible Role of the Late
Leader Region in Initiation Site Recognition. J Mol Biol 1979, 134: 219-240 (A)
Legon S, Flavell AJ, Cowie A, Kamen R: Amplification in the Leader Sequence of Late
Polyoma Virus mRNAs. Cell 1979, 16: 373-388 (B)
Lescure B, Yaniv M: Denaturation Map of Polyoma DNA. J Virol 1975, 16(3): 720-724
Lev Z, Kamen R, Manor H: Topography of Polyoma Virus-Specific Giant Nuclear RNA
Molecules Containing Poly(A) Sequences. Virology 1979, 93: 445-457
Li P, Nakanishi A, Shum D, Sun PC, Salazar AM, Fernandez CF, Chan S, Kasamatsu H:
Simian Virus 40 Vp1 DNA-Binding Domain Is Functionally Separable from the
Overlapping Nuclear Localization Signal and Is Required for Effective Virion Formation
and Full Viability. J Virol 2001, 75(16): 7321-7329
Li D, Dower K, Ma Y, Tian Y, Benjamin TL: A tumor host range selection procedure
identifies p150sal2 as a target of polyoma virus large T antigen. Proc Natl Acad Sci USA
2001, 98(25): 14619-14624
Li D, Tian Y, Ma Y, Benjamin TL: p150sal2 Is a p53-Independent Regulator of
p21WAF1/CIP. Mol Cell Biol 2004, 24(9): 3885-3893
Liebl D, Difato F, Hornikova L, Mannova P, Stokrova J, Forstova J: Mouse
Polyomavirus Enters Early Endosomes, Requires Their Acidic pH for Productive
Infeciton, and Meets Transferrin Cargo in Rab11-Positive Endosomes. J Virol 2006,
80(9): 4610-4622
Linzer DI, Levine AJ: Characterization of a 54K dalton cellular SV40 tumor antigen
present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979,
17: 43-52
Liu H, Adler AS, Segal E, Chang HY: A Transcriptional Program Mediating Entry into
Cellular Quiescence. PLoS Genet 2007, 3(6): 996-1008
Liu Z, Carmichael GG: Polyoma virus early-late switch: Regulation of late RNA
accumulation by DNA replication. Proc Natl Acad Sci USA 1993, 90: 8494-8498
Lomax M, Fried M: Polyoma virus disrupts ARF signaling to p53. Oncogene 2001, 20:
4951-4960

127	
  

	
  
Lundblad JR, Kwok RPS, Laurence ME, Harter ML, Goodman RH: Adenoviral E1Aassociated protein p 300 as a functional homologue of the transcriptional co-activator
CBP. Nature 1995, 374: 85-88
Luthman H, Nilsson M, Mangusson G: Non-contiguous Segments of the Polyoma
Genome Required in cis for DNA Replication. J Mol Biol 1982, 161: 533-550
Magnuson B, Rainey EK, Benjamin TL, Baryshev M, Mkrtchian S, Tsai B: ERp29
Triggers a Conformational Change in Polyomavirus to Stimulate Membrane Binding.
Mol Cell 2005, 20: 289-300
Magnusson G, Nilsson M, Dilworth SM, Smolar N: Characterization of Polyoma Mutants
with Altered Middle and Large T-Antigens. J Virol 1981, 39(3): 673-683
Majerus PW, Ross TS, Cunningham TW, Caldwell KK, Jefferson AB, Bansal VS:
Recent Insights in Phosphatidylinositol Signaling. Cell 1990, 63: 459-465
Mannova P, Forstova J: Mouse Polyomavirus Utilizes Recycling Endosomes for a Traffic
Pathway Independent of COPI Vesicle Transport. J Virol 2003, 77(3): 1672-1681
Martelli F, Iacobini C, Caruso M, Felsani A: Characterization of Two Novel YY1
Binding Sites in the Polyomavirus Late Promoter. J Virol 1996, 70: 1433-1438
Martin ME, Piette J, Yaniv M, Tang W, Folk WR: Activation of the polyomavirus
enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins.
Proc Natl Acad Sci USA 1988, 85: 5839-5843
Maxam AM, Gilbert W: A new method for sequencing DNA. Proc Natl Acad Sci USA
1977, 74(2): 560-564
McMillen J, Consigli RA: Characterization of Polyoma DNA-Protein Complexes I.
Electrophoretic Identification of the Proteins in a Nucleoprotein Complex Isolated from
Polyoma-Infected Cells. J Virol 1974, 14(6): 1326-1336
Meili R, Cron P, Hemmings BA, Ballmer-Hofer K: Protein kinase B/Akt is activated by
polyomavirus middle-T antigen via a phosphatidylinositol 3-kinase-dependent
mechanism. Oncogene 1998, 16: 903-907
Montross L, Watkins S, Moreland RB, Mamon H, Caspar DLD, Garcea RL: Nuclear
Assembly of Polyomavirus Capsids in Insect Cells Expressing the Major Capsid Protein
VP1. J Virol 1991, 65(9): 4991-4998
Moule MG, Collins CH, McCormick F, Fried M: Role for PP2A in ARF Signaling to
p53. Proc Natl Acad Sci USA 2004, 101(39): 14063-14066

128	
  

	
  
Muir K, Hazim A, He Y, Peyressatre M, Kim DY, Song X, Beretta L: Proteomic and
lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma.
Cancer Res 2013, 73(15): 4722-4731
Mullane KP, Ratnofsky M, Cullere X, Schaffhausen B: Signaling from Polyomavirus
Middle T and Small T Defines Different Roles for Protein Phosphatase 2A. Mol Cell Biol
1998, 18(2): 7556-7564
Muller WJ, Mueller CR, Mes A Hassel JA: Polyomavirus Origin for DNA Replication
Comprises Multiple Genetic Elements. J Virol 1983, 47(3): 586-599
Nemethova M, Wintersberger E: Polyomavirus Large T Antigen Binds the
Transcriptional Coactivator Protein p300. J Virol 1999, 73(2): 1734-1739
Nicholson PR, Empereur S, Glover HR, Dilworth SM: ShcA tyrosine phosphorylation
sites can replace ShcA binding in signaling by middle T-antigen. EMBO J 2001, 20(22):
6337-6346
Nothias J, Weinmann R, Blangy D, Melin F: Analysis of Transcription Factors Binding
to the Duplicated PEA1 and PEA3 Sites That Are Required for Polyomavirus Mutant
Expression in PCC4 Embryonic Carcinoma Cells. J Virol 1993, 67(6): 3036-3047
Ntambi M: Regulation of steroyl-CoA desaturase by polyunsaturated fatty acids and
cholesterol. J Lipid Res 1999, 40(9): 1549-1558
Ogris E, Mudrak I, Mak E, Gibson D, Pallas DC: Catalytically Inactive Protein
Phosphatase 2A Can Bind to Polyomavirus Middle Tumor Antigen and Support Complex
formation with pp60c-src. J Virol 1999, 73(9): 7390-7398
Oxman MN, Tekemoto KK, Eckhart W: Polyoma T Antigen Synthesis by Temperaturesensitive Mutants of Polyoma Virus. Virology 1972, 49: 675-682
Pallas DC, Cherington V, Morgan W, DeAnda J, Kaplan D, Schaffhausen B, Roberts
TM: Cellular Proteins that Associate with Middle and Small T Antigens of Polyomavirus.
J Virol 1988, 62(11): 3934-3940
Palkova Z, Spanielova H, Gottifredi V, Hollanderova D, Forstova J, Amati P: The
polyomavirus major capsid protein VP1 interacts with the nuclear matrix regulatory
protein YY1. FEBS 2000, 467: 359-364
Pallas DC, Sharik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL, Roberts TM:
Polyoma Small and Middle T Antigens and SV40 Small t Antigen Form Stable
Complexes with Protein Phosphatase 2A. Cell 1990, 60: 167-176

129	
  

	
  
Paschen SA, Rothbauer U, Kaldi K, Bauer MF, Neupert W, Brunner M: The role of the
TIM8-13 complex in the import of Tim23 into mitochondria. EMBO J 2000, 19(23):
6392-6400
Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I,
Grognani F, Pawson T, Pelicci PG: A Novel Transforming Protein (SHC) with and SH2
Domain Is Implicated in Mitogenic Signal Transduction. Cell 1992, 70: 93-104
Piette J, Kryszke M, Yaniv M: Specific interaction of cellular factors with the B enhancer
of polyoma virus. EMBO J 1985, 4: 2675-2685
Piette J, Yaniv M: Two different factors bind to the α-domain of the polyoma virus
enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J 1987,
6:1331-1337
Pilon AA, Desjardins P, Hassell JA, Mes-Masson A: Functional Implications of
Mutations within Polyomavirus Large T Antigen Rb-Binding Domain: Effects on pRb
and p107 Binding In Vitro and Immortalization Activity In Vivo. J Virol 1996, 70(7):
4457-4465
Piper PW: Polyoma Virus Transcription Early During Productive Infection of Mouse 3T6
Cells. J Mol Biol 1979, 131: 399-407
Porath HT, Carmi S, Levanon EY: A genome-wide map of hyper-edited RNA reveals
numerous new sites. Nat Commun 2014, 5: 4726
Qian W, Wilman KG: Polyoma Virus Middle T and Small t Antigens Cooperate to
Antagonize p53-induced Cell Cycle Arrest and Apoptosis. Cell Growth Differ 2000, 11:
31-39
Radloff R, Bauer W, Vinograd J: A Dye-Buoyant-Density Method for the Detection and
Isolation of Closed Circular Duplex DNA: The Closed Circular DNA in HeLa Cells.
Proc Natl Acad Sci USA 1967, 57: 1514-1521
Raptis L, Lamfrom H, Benjamin TL: Regulation of Cellular Phenotype and Expression of
Polyomavirus Middle T Antigen in Rat Fibroblasts. Mol Cell Biol 1985, 5(9): 2476-2485
Rassoulzadegan M, Naghashfar Z, Cowie A, Carr A, Grisoni M, Kamen R, Cuzin F:
Expression of the large T protein of polyoma virus promotes the establishment in culture
of “normal” rodent fibroblast cell lines. Proc Natl Acad Sci USA 1983, 80: 4354-4358
Rhee E, Carmichael GG: Translational Efficiencies of Polyomavirus Late mRNA
Molecules That Differ in the Sequences of Their 5’ Noncoding Late Leader Exons. J
Virol 1989, 63: 432-435

130	
  

	
  
Richterova Z, Liebl D, Horak M, Palkova Z, Stokrova J, Hozak P, Korb J, Forstova J:
Caveolae Are Involved in the Trafficking of Mouse Polyomavirus Virions and Artificial
VP1 Pseudocapsids toward Cell Nuclei. J Virol 2001, 75(22): 10880-10891
Roblin R, Harle E, Dulbecco R: Polyoma Virus Proteins I. Multiple Virion Components.
Virology 1971, 45(3): 555-566
Rodriguez-Viciana P, Collins C, Fried M: Polyoma and SV40 proteins differentially
regulate PP2A to activate distinct cellular signaling pathways involved in growth control.
Proc Natl Acad Sci USA 2006, 103(51): 19290-19295
Rosenthal LJ, Salomon C, Weil R: Isolation and characterization of poly(A)-containing
intranuclear polyoma-specific “giant” RNAs. Nucleic Acids Res 1976, 3(5): 1167-1183
Rowe WP, Hartley JW, Law LW, Huebner RJ: Studies of Mouse Polyoma Infection. III.
Distribution of Antibodies in Laboratory Mouse Colonies. J Exp Med 1959, 109(5): 449462
Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG: Formation of ShcGrb2 complexes is necessary to induce neoplastic transformation by over expression of
Shc proteins. Oncogene 1994, 9(10): 2827-2836
Salomon C, Turler H, Weil R: Polyoma-induced stimulation of cellular RNA synthesis is
paralleled by changed expression of the viral genome. Nucleic Acids Res 1977, 4(5):
1483-1503
Salunke DM, Caspar DLD, Garcea RL: Polymorphism in the assembly of polyomavirus
capsid protein VP1. Biophys J 1989, 56: 887-900
Sambrook J, Westphal H, Srinivasan PR, Dulbecco R: The Integrated State of Viral DNA
in SV40-Transformed Cells. Proc Natl Acad Sci USA 1968, 60(4): 1288-1295
Schaffhausen BS, Benjamin TL: Comparison of Phosphorylation of Two Polyoma Virus
Middle T Antigens In Vivo and In Vitro. J Virol 1981, 40(1): 184-196
Schaffhausen BS, Benjamin TL: Deficiency in histone acetylation in nontransforming
host range mutants of polyoma virus. Proc Natl Acad Sci USA 1976, 73(4): 1092-1096
Schaffhausen BS, Dorai H, Arakere G, Benjamin TL: Polyoma Virus Middle T Antigen:
Relationship to Cell Membranes and Apparent Lack of ATP-Binding Activity. Mol Cell
Biol 1982, 2(10): 1187-1198
Schaffhausen BS, Liang TJ, Carmichael GG, Benjamin TL: Residual Transforming
Activity of PY1178T, a Mutant Lacking the Principal in Vitro Tyrosine Phosphorylation
Site, Is Not Affected by Removal of the Secondary Tyrosine Phosphorylation Site at
Residue 322. Virology 1985, 143: 671-675

131	
  

	
  

Schlegel R, Benjamin TL: Cellular Alterations Dependent upon the Polyoma Virus Hf-t
Function: Separation of Mitogenic from Transforming Capacities. Cell 1978, 14: 587-599
Schuchner S, Wintersberger E: Binding of Polyomavirus Small T Antigen to Protein
Phosphatase 2A Is Required for Elimination of p27 and Support of S-Phase Induction in
Concert with Large T Antigen. J Virol 1999, 73(11): 9266-9273
Schutte J, Viallet J, Nau M, Segal S, Fedorko J, Minna J: jun-B Inhibits and c-fos
Stimulates the Transforming and Trans-Activating Activities of c-jun. Cell 1989, 59:
987-997
Seehafer JG, Weil R: Synthesis of Polyoma Virus Structural Polypeptides in Mouse
Kidney Cells. Virology 1974, 58(1): 75-85
Serunian LA, Auger KR, Roberts TM, Cantley LC: Production of Novel
Phosphatidylinositides In Vivo Is Linked to Cell Transformation by Polyomavirus
Middle T Antigen. J Virol 1990, 64(10): 4718-4725
Shaulian E, Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 2002, 4(5):
E131-E136
Sheng Q, Denis D, Ratnofsky M, Roberts TM, DeCaprio JA, Schaffhausen B: The DnaJ
Domain of Polyomavirus Large T Antigen is Required to Regulate pRb Family Tumor
Suppressor Function. J Virol 1997, 71(12): 9410-9416
Sheng Q, Love TM, Schaffhausen B: J Domain-Independent Regulation of the Rb Family
by Polyomavirus Large T Antigen. J Virol 2000, 74(11): 5280-5290
Shivakumar CV, Das GC: The A Enhancer of Polyomavirus: Protein-Protein Interactions
for the Differential Early and Late Promoter Function under Nonreplicating Conditions.
Intervirology 1998, 41: 103-109
Siegler R, Benjamin TL: Oncogenicity of wild type and mutant strains of polyoma virus.
Proc Amer Assoc Cancer Research 1975, 16: 99
Silver J, Schaffhausen B, Benjamin T: Tumor Antigens Induced by Nontransforming
Mutants of Polyoma Virus. Cell 1978, 15: 485-496
Smart JE, Ito Y: Three Species of Polyoma Virus Tumor Antigens Share Common
Peptides Probably near the Amino Termini of the Proteins. Cell 1978, 15: 1427-1437
Smith AE, Kamen R, Mangel WF, Shure H, Wheeler T: Location of the Sequences
Coding for Capsid Proteins VP1 and VP2. Cell 1976, 9: 481-487

132	
  

	
  
Soeda E, Arrand JR, Smolar N, Griffin BE: Sequence from Early Region of Polyoma
Virus DNA Containing Viral Replication Origin and Encoding Small, Middle, and (Part
of) Large T Antigens. Cell 1979, 17: 357-370
Soeda E, Arrand JR, Smolar N, Walsh JE, Griffin BE: Coding potential and regulatory
signals of the polyoma virus genome. Nature 1980, 283: 445-453
Spanielova H, Fraiberk M, Suchanova J, Soukup J, Forstova J: The encapsidation of
polyomavirus is not defined by a sequence-specific encapsidation signal. Virology 2014,
450-451: 122-131
Staneloni R, Fluck MM, Benjamin TL: Host Range Selection of Transformationdefective hr-t Mutants of Polyoma Virus. Virology 1977, 77: 598-609
Stewart SE, Eddy BE, Borgese N: Neoplasms in mice inoculated with a tumor
agent carried in tissue culture. J Natl Cancer Inst 1958, 20: 1223-1243
Su W, Liu W, Schaffhausen BS, Roberts TM: Association of Polyomavirus Middle
Tumor Antigen with Phospholipase C-gamma1. J Biol Chem 1995, 270(21): 1233112334
Sullivan CS, Grundhoff AT, Tevethia S, Pipas JT, Ganem D: SV40-encoded microRNAs
regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005,
435: 682-686
Sullivan CS, Sung CK, Pack CD, Grundhoff A, Lukacher AE, Benjamin TL, Ganem D:
Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not
essential for experimental infection. Virology 2009, 387(1): 157-167
Talmage DA, Freund R, Young AT, Dahl J, Dawe CJ, Benjamin TL: Phosphorylation of
Middle T by pp60c-src: A Switch for Binding of Phosphatidylinositol 3-kinase and
Optimal Tumorigenesis. Cell 1989, 59: 55-65
Treisman R, Kamen R: Structure of Polyoma Virus Late Nuclear RNA. J Mol Biol 1981,
148: 273-301 (A)
Treisman R, Novak U, Favaloro J, Kamen R: Transformation of rat cells by an altered
polyoma virus genome expressing only the middle-T protein. Nature 1981, 292: 595-600
(B)
Triezenberg SJ, Folk W: Essential Nucleotides in the Polyomavirus Origin Region. J
Virol 1984, 51(2): 437-444
Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, Rapoport TA: Gangliosides are
receptors for murine polyoma virus and SV40. EMBO J 2003, 22(17): 4346-4355

133	
  

	
  
Turler H, Salomon C, Allet B, Weil R: Mapping of the three species of polyoma mRNA.
Proc Natl Acad Sci USA 1976, 73(5): 1480-1484
Tycowski KT, Shu MD, Steitz JA: Requirement for intron-encoded U22 small nucleolar
RNA in 18S ribosomal RNA maturation. Science 1994, 266(5190): 1558-1561
Tyndall C, La Mantia G, Thacker CM, Favaloro J, Kamen R: A region of the polyoma
virus genome between the replication origin and late protein coding sequences is required
in cis for both early gene expression and viral DNA replication. Nucleic Acids Res 1981,
9(23): 6231-6250
Van Holde KE (1988) Chromatin. Springer-Verlag, New York
Vasseur M, Kress C, Montreau N, Blangy D: Isolation and characterization of polyoma
virus mutants able to develop in embryonal carcinoma cells. Proc NAtl Acad Sci USA
1980, 77(2): 1068-1072
Veldman G, Lupton S, Kamen R: Polyomavirus Enhancer Contains Mutiple Redundant
Sequence Elements That Activate Both DNA Replication and Gene Expression. Mol Cell
Biol 1985, 5(4): 649-658
Vinograd J, Lebowitz J, Radloff R, Watson R, Laipis P: The Twisted Circular Form of
Polyoma Viral DNA. Proc Natl Acad Sci USA 1965, 53: 1104-1111
Vinograd J, Lebowitz J, Watson R: Early and Late Helix-Coil Transitions in Closed
Circular DNA The Number of Superhelical Turns in Polyoma DNA. J Mol Biol 1968, 33:
173-197
Vogt M, Dulbecco R: Virus-cell interaction with a tumor-producing virus. Proc Natl
Acad Sci USA 1960: 365-370
Vogt M, Dulbecco R: Studies on Cells Rendered Neoplastic by Polyoma Virus: the
Problem of the Presence of Virus-related Materials. Virology 1962, 16: 41-51
Vuorio E, Crombrugghe B: The Family of Collagen Genes. Annu Rev Biochem 1990,
59:837-872
Walter G, Ruediger R, Slaughter C, Mumby M: Association of protein phosphatase 2A
with polyoma virus medium tumor antigen. Proc Natl Acad Sci USA 1990, 87: 25212525
Wang EH, Friedman PN, Prives C: The Murine p53 Protein Blocks Replication of SV40
DNA In Vitro by Inhibiting the Initiation Functions of SV40 Large T Antigen. Cell 1989,
57: 379-392

134	
  

	
  
Wang EH, Prives C: DNA Helicase and Duplex DNA Fragment Unwinding Activities of
Polyoma and Simian Virus 40 Large T Antigen Display Similarities and Differences. J
Biol Chem 1991, 266(19): 12668-12675
Wasylyk B, Wasylyk C, Flores P, Begue A, Leprince D, Stehelin D: The c-ets protooncogenes encode transcription factors that cooperate with c-Fos and c-Jun for
transcriptional activation. Nature 1990, 346: 191-193
Wasylyk C, Flores P, Gutman A, Wasylyk B: PEA3 is a nuclear target for transcription
activation by non-nuclear oncogenes. EMBO J 1989, 8: 3371-3378
Weil R: The Denaturation and The Renaturation of the DNA of Polyoma Virus. Proc
Natl Acad Sci USA 1963, 49(4): 480-487 (A)
Weil R, Vinograd J: The Cyclic Helix and Cyclic Coil Forms of Polyoma Viral DNA.
Proc Natl Acad Sci USA 1963, 50: 730-738 (B)
Whitman M, Downes CP, Keeler M, Keller T, Cantley L: Type I phosphatidylinositol
kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature
1988, 332: 644-646
Whitman M, Kaplan DR, Schaffhausen B, Cantley L, Roberts TM: Association of
phosphatidylinositol kinase activity with polyoma middle-T competent for
transformation. Nature 1985, 315: 239-242
Wildy P, Stoker MGP, Macpherson IA, Horne RW: The Fine Structure of Polyoma
Virus. Virology 1960, 11(2): 444-457
Winocour E: Purification of Polyoma Virus. Virology 1963, 19(2): 158-168
Winocour E, Sachs L: A Plaque Assay for the Polyoma Virus. Virology 1959, 8: 397-400
Yamasaki S, Nishida K, Yoshida Y, Itoh M, Hibi M, Hirano T: Gab1 is required for EGF
receptor signaling and the transformation by activated ErbB2. Oncogene 2003, 22: 15461556
Yaniv M, Croissant O, Cuzin F: Location of the T4 Gene 32 Protein-Binding Site on
Polyoma Virus DNA. Biochem Bioph Res Co 1974, 57(4): 1074-1079
Yoo W, Martin ME, Folk WR: PEA1 and PEA3 Enhancer Elements Are Primary
Components of the Polyomavirus Late Transcription Initiatior Element. J Virol 1991, 65:
5391-5400
Zhu S, Xiang J, Chen T, Chen L, Yang L: Prediction of constitutive A-to-I editing sites
from human transcritomes in the absence of genomic sequences. BMC Genomics 2013,
14: 206

135	
  

	
  

Zhu Z, Veldman G, Cowie A, Carr A, Schaffhausen B, Kamen R: Construction and
Functional Characterization of Polyomavirus Genomes that Separately Encode The Three
Early Proteins. J Virol 1984, 51(1): 170-180
Zuckermann M, Manor H, Parker J, Kamen R: Electron microscopic demonstration of the
presence of amplified sequences at the 5’-ends of the polyoma virus late mRNAs. Nucleic
Acids Res 1980, 8(7): 1505-1519
Zullo J, Stiles CD, Garcea RL: Regulation of c-myc and c-fos mRNA levels by
polyomavirus: Distinct roles for the capsid protein VP1 and the viral early proteins. Proc
Natl Acad Sci USA 1987, 84: 1210-1214

136	
  

